<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="pro70024" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Protein Sci</journal-id><journal-id journal-id-type="iso-abbrev">Protein Sci</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1469-896X</journal-id><journal-id journal-id-type="publisher-id">PRO</journal-id><journal-title-group><journal-title>Protein Science : A Publication of the Protein Society</journal-title></journal-title-group><issn pub-type="ppub">0961-8368</issn><issn pub-type="epub">1469-896X</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39731543</article-id><article-id pub-id-type="pmc">PMC11681614</article-id><article-id pub-id-type="doi">10.1002/pro.70024</article-id><article-id pub-id-type="publisher-id">PRO70024</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A crucial active site network of titratable residues guides catalysis and <styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup> binding in human succinic semialdehyde dehydrogenase</article-title><alt-title alt-title-type="left-running-head">Cesaro et al.</alt-title></title-group><contrib-group><contrib id="pro70024-cr-0001" contrib-type="author"><name><surname>Cesaro</surname><given-names>Samuele</given-names></name><xref rid="pro70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pro70024-cr-0002" contrib-type="author"><name><surname>Orlando</surname><given-names>Marco</given-names></name><xref rid="pro70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="pro70024-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pro70024-cr-0003" contrib-type="author"><name><surname>Bettin</surname><given-names>Ilaria</given-names></name><xref rid="pro70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pro70024-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="pro70024-cr-0004" contrib-type="author"><name><surname>Longo</surname><given-names>Carmen</given-names></name><xref rid="pro70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pro70024-cr-0005" contrib-type="author"><name><surname>Spagnoli</surname><given-names>Giulia</given-names></name><xref rid="pro70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pro70024-cr-0006" contrib-type="author"><name><surname>de Laureto</surname><given-names>Patrizia Polverino</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0367-6781</contrib-id><xref rid="pro70024-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="pro70024-cr-0007" contrib-type="author"><name><surname>Molla</surname><given-names>Gianluca</given-names></name><xref rid="pro70024-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="pro70024-cr-0008" contrib-type="author" corresp="yes"><name><surname>Bertoldi</surname><given-names>Mariarita</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2337-9928</contrib-id><xref rid="pro70024-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>mita.bertoldi@univr.it</email></address></contrib></contrib-group><aff id="pro70024-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neuroscience, Biomedicine and Movement Sciences, Section of Biochemistry</named-content>
<institution>University of Verona</institution>
<city>Verona</city>
<country country="IT">Italy</country>
</aff><aff id="pro70024-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Biotechnology and Life Sciences</named-content>
<institution>University of Insubria</institution>
<city>Varese</city>
<country country="IT">Italy</country>
</aff><aff id="pro70024-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Biotechnology e Biosciences</named-content>
<institution>University of Milano&#x02010;Bicocca</institution>
<city>Milan</city>
<country country="IT">Italy</country>
</aff><aff id="pro70024-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Biology</named-content>
<institution>Friedrich&#x02010;Alexander University</institution>
<city>Erlangen&#x02010;N&#x000fc;rnberg</city>
<country country="DE">Germany</country>
</aff><aff id="pro70024-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmaceutical and Pharmacological Sciences</named-content>
<institution>University of Padova</institution>
<city>Padova</city>
<country country="IT">Italy</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>
Mariarita Bertoldi, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona, 37134 Verona, Italy.<break/>
Email: <email>mita.bertoldi@univr.it</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2024</year></pub-date><volume>34</volume><issue seq="370">1</issue><issue-id pub-id-type="doi">10.1002/pro.v34.1</issue-id><elocation-id>e70024</elocation-id><history>
<date date-type="rev-recd"><day>13</day><month>12</month><year>2024</year></date>
<date date-type="received"><day>15</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>16</day><month>12</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 The Protein Society--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">Protein Science</italic> published by Wiley Periodicals LLC on behalf of The Protein Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PRO-34-e70024.pdf"/><abstract><title>Abstract</title><p>Human succinic semialdehyde dehydrogenase is a mitochondrial enzyme fundamental in the neurotransmitter &#x003b3;&#x02010;aminobutyric acid catabolism. It catalyzes the NAD<sup>+</sup>&#x02010;dependent oxidative degradation of its derivative, succinic semialdehyde, to succinic acid. Mutations in its gene lead to an inherited neurometabolic rare disease, succinic semialdehyde dehydrogenase deficiency, characterized by mental and developmental delay. Due to the poor characterization of this enzyme, we carried out evolutionary and kinetic investigations to contribute to its functional behavior, a prerequisite to interpreting pathogenic variants. An in silico analysis shows that succinic semialdehyde dehydrogenases belong to two families, one human&#x02010;like and the other of bacterial origin, differing in the oligomeric state and in a network of active site residues. This information is coupled to the biophysical&#x02013;biochemical characterization of the human recombinant enzyme uncovering that (i) catalysis proceeds by an ordered bi&#x02013;bi mechanism with NAD<sup>+</sup> binding before the aldehyde that exerts a partial non&#x02010;competitive inhibition; (ii) a stabilizing complex between the catalytic Cys340 and NAD<sup>+</sup> is observed and interpreted as a protective mechanism; and (iii) a concerted non&#x02010;covalent network assists the action of the catalytic residues Cys340 and Glu306. Through mutational analyses of Lys214, Glu306, Cys340, and Glu515 associated with pH studies, we showed that NAD<sup>+</sup> binding is controlled by the dyad Lys214&#x02010;Glu515. Moreover, catalysis is assured by proton transfer exerted by the same dyad networked with the catalytic Glu306, involved in catalytic Cys340 deprotonation/reprotonation. The identification of this weak bond network essential for cofactor binding and catalysis represents a first step to tackling the molecular basis for its deficiency.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="pro70024-kwd-0001">bioinformatic and evolutionary analysis</kwd><kwd id="pro70024-kwd-0002">enzymatic mechanism</kwd><kwd id="pro70024-kwd-0003">kinetics</kwd><kwd id="pro70024-kwd-0004">succinic semialdehyde dehydrogenase</kwd><kwd id="pro70024-kwd-0005">succinic semialdehyde dehydrogenase deficiency</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>De Neu Asociacion de Enfermedades de los Neurotrasmisores</funding-source></award-group><award-group id="funding-0002"><funding-source>SSADH&#x02010;Defizit e.V</funding-source></award-group></funding-group><counts><fig-count count="10"/><table-count count="3"/><page-count count="22"/><word-count count="12900"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:28.12.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="pro70024-cit-9001">
<string-name>
<surname>Cesaro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Orlando</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bettin</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Longo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Spagnoli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>de Laureto</surname>
<given-names>PP</given-names>
</string-name>, et al. <article-title>A crucial active site network of titratable residues guides catalysis and <styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup> binding in human succinic semialdehyde dehydrogenase</article-title>. <source>Protein Science</source>. <year>2025</year>;<volume>34</volume>(<issue>1</issue>):<elocation-id>e70024</elocation-id>. <pub-id pub-id-type="doi">10.1002/pro.70024</pub-id>
</mixed-citation>
</p><fn-group id="pro70024-ntgp-0001"><fn id="pro70024-note-0001" fn-type="equal"><p>Samuele Cesaro and Marco Orlando contributed equally to this study and are co&#x02010;first authors.</p></fn><fn id="pro70024-note-0002"><p>
<bold>Review Editor:</bold> Lynn Kamerlin</p></fn></fn-group></notes></front><body id="pro70024-body-0001"><sec id="pro70024-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Human succinic semialdehyde dehydrogenase (hSSADH) (EC 1.2.1.24) is a mitochondrial enzyme belonging to the aldehyde dehydrogenase (ALDH) superfamily (Jackson et al.&#x000a0;<xref rid="pro70024-bib-0034" ref-type="bibr">2011</xref>). It plays a crucial role in the metabolism of &#x003b3;&#x02010;aminobutyric acid (GABA) (Scheme&#x000a0;<xref rid="pro70024-fig-0008" ref-type="fig">1</xref>). GABA is synthesized by decarboxylation of glutamate catalyzed by glutamate decarboxylase (GAD) and is then transaminated to succinic semialdehyde (SSA) by GABA aminotransferase (GABA&#x02010;AT). Thereafter, hSSADH catalyzes the oxidation of SSA into succinic acid (SA), with the concomitant reduction of oxidized nicotinamide adenine dinucleotide (NAD<sup>+</sup>) to its reduced form NADH. SA connects the GABA neurotransmitter pathway to the tricarboxylic acids (TCA) cycle, implying that the control of its level plays a distinct role in metabolism.</p><fig position="float" fig-type="SCHEME" id="pro70024-fig-0008"><label>SCHEME 1</label><caption><p>Metabolic pathways of GABA. The red cross denotes the misfunctioning or absence of hSSADH, leading to GABA and GHB accumulation (red arrows).</p></caption><graphic xlink:href="PRO-34-e70024-g009" position="anchor" id="jats-graphic-1"/></fig><p>An impairment of hSSADH leads to increased amounts of both GABA and the catabolite &#x003b3;&#x02010;hydroxybutyric acid (GHB), a toxic compound at high concentrations (Malaspina et al.&#x000a0;<xref rid="pro70024-bib-0050" ref-type="bibr">2009</xref>). About 70 variants, mainly missense, in <italic toggle="yes">ALDH5A1</italic>, the human gene coding for hSSADH (GRCh38: chr6:24,494,867&#x02013;24,537,207; cytogenetic band 6p22.3), are responsible for a rare recessive genetic disorder, SSADH deficiency (OMIM #271980) identified in about 450 patients (Akaboshi et al.&#x000a0;<xref rid="pro70024-bib-0003" ref-type="bibr">2003</xref>; Brennenstuhl et al.&#x000a0;<xref rid="pro70024-bib-0007" ref-type="bibr">2020</xref>; DiBacco et al.&#x000a0;<xref rid="pro70024-bib-0016" ref-type="bibr">2020</xref>; Didiasova et al.&#x000a0;<xref rid="pro70024-bib-0018" ref-type="bibr">2024</xref>; Menduti et al.&#x000a0;<xref rid="pro70024-bib-0053" ref-type="bibr">2018</xref>; Pop et al.&#x000a0;<xref rid="pro70024-bib-0066" ref-type="bibr">2020</xref>). The symptoms include mental and developmental delay, ataxia, and hypotonia coupled with seizure, psychiatric episodes, and autism, which tend to worsen with age progression (Didi&#x000e1;&#x00161;ov&#x000e1; et al.&#x000a0;<xref rid="pro70024-bib-0017" ref-type="bibr">2020</xref>; Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0082" ref-type="bibr">2023a</xref>; Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0083" ref-type="bibr">2023b</xref>; Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0084" ref-type="bibr">2024b</xref>). The pharmacological treatments are palliative and aimed to ameliorate symptoms (Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0081" ref-type="bibr">2024a</xref>). A recent genotype&#x02010;to&#x02010;phenotype correlation based on structural analysis has been proposed (Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0085" ref-type="bibr">2023c</xref>).</p><p>As with many other monogenic diseases, the broad spectrum of symptoms can also be due to the difference in variants that can affect the functionality of hSSADH by distinctive molecular mechanisms. Attempts to model the disease in mice by both enzyme replacement therapy of the wild&#x02010;type (WT) hSSADH or gene therapy with its cDNA (Lee et al.&#x000a0;<xref rid="pro70024-bib-0047" ref-type="bibr">2021</xref>; Lee et al.&#x000a0;<xref rid="pro70024-bib-0046" ref-type="bibr">2024</xref>) are ongoing. However, the knowledge of the structural determinants responsible for the activity of hSSADH is essential to develop an effective treatment.</p><p>Surprisingly, hSSADH is a rather neglected enzyme. In literature, only a few papers (up to 1992) reported the investigation of the reaction carried out by the enzyme isolated from the human brain (Chambliss and Gibson&#x000a0;<xref rid="pro70024-bib-0013" ref-type="bibr">1992</xref>; Embree and Albers&#x000a0;<xref rid="pro70024-bib-0021" ref-type="bibr">1964</xref>; Ryzlak and Pietruszko&#x000a0;<xref rid="pro70024-bib-0071" ref-type="bibr">1988</xref>). More recently, the enzyme was cloned and purified in recombinant form (Chambliss et al.&#x000a0;<xref rid="pro70024-bib-0012" ref-type="bibr">1995</xref>; Kang et al.&#x000a0;<xref rid="pro70024-bib-0037" ref-type="bibr">2005</xref>) and obtained in high yields with a <italic toggle="yes">k</italic>
<sub>cat</sub> of about 1.7&#x02009;s<sup>&#x02212;1</sup> and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> for SSA and NAD<sup>+</sup> of 6.3 and 125&#x02009;&#x003bc;M, respectively (Kang et al.&#x000a0;<xref rid="pro70024-bib-0037" ref-type="bibr">2005</xref>). In the same paper, it was demonstrated that the enzyme was highly expressed in the brain, liver, skeletal muscle, and kidney. In 2009, the structure of hSSADH was solved (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>) as a homotetramer (dimer of dimers) composed of four identical monomers, each of 535 residues. The monomeric subunit is composed of a mitochondrial peptide sequence (residues 1&#x02013;47), a NAD<sup>+</sup> binding domain (residues 48&#x02013;173, 196&#x02013;307, and 509&#x02013;524), a catalytic (or substrate) domain (residues 308&#x02013;508, containing the catalytic residues Cys340 and Glu306), and an oligomerization domain (residues 174&#x02013;195 and 525&#x02013;535). Although a reaction mechanism for hSSADH has not been determined yet, the generally accepted mechanism of ALDH (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>; Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>) involves the essential catalytic roles of a cysteine and a glutamate residue (Cys340 and Glu306 for hSSADH) (Scheme&#x000a0;<xref rid="pro70024-fig-0009" ref-type="fig">2</xref>).</p><fig position="float" fig-type="SCHEME" id="pro70024-fig-0009"><label>SCHEME 2</label><caption><p>Proposed mechanism of reaction of hSSADH highlighting the role of Cys340 as a nucleophile and of Glu306 as acid&#x02013;base catalyst. The catalytic Cys340 is deprotonated by the catalytic Glu306 (through a water molecule) (step 1) to generate a thiolate anion that (step 2) makes a nucleophilic attack to the formyl carbon of SSA. The produced thiohemiacetal intermediate transfers the hydride to NAD<sup>+</sup>, which is reduced to NADH (step 3) with the concomitant formation of the thioester intermediate. Glu306 acts as a general base (through a water molecule) to trigger the nucleophilic attack of a hydroxyl ion on the carbonyl carbon of the ester (step 4). This generates a tetrahedral intermediate with subsequent release of succinic acid (SA) and of Cys340 thiolate, which is finally reprotonated by Glu306 (step 5).</p></caption><graphic xlink:href="PRO-34-e70024-g001" position="anchor" id="jats-graphic-3"/></fig><p>The activity of hSSADH is further shown to be regulated by the redox state. Oxidizing conditions lead to inactivation with the formation of a disulfide bond between Cys340 and the adjacent Cys342 (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>). This mechanism is reversible and would enable the sensitivity of the human enzyme to fluctuating redox conditions within the mitochondria (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>). Only another SSADH of bacterial source has been recently reported to bear two nearby cysteine residues capable of a redox mechanism similar to the one proposed for the human enzyme (Paladkong et al.&#x000a0;<xref rid="pro70024-bib-0062" ref-type="bibr">2022</xref>; Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>).</p><p>Several homologous enzymes with SSA oxidation activity have been reported and biochemically characterized. Only a few of them are eukaryotic and show diversity in oligomerization state (dimer or tetramer), cofactor preference (NAD<sup>+</sup> or NADP<sup>+</sup>) and kinetics (Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref> and references therein), but a systematic evolutionary overview is lacking, considering also that the Aldehyde Dehydrogenase Gene Superfamily Resource Center is now inaccessible (Black and Vasiliou&#x000a0;<xref rid="pro70024-bib-0006" ref-type="bibr">2009</xref>).</p><table-wrap position="float" id="pro70024-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>ALDH proteins coded by human <italic toggle="no">ALDH</italic> genes and SSADH proteins from species other than <italic toggle="no">Homo sapiens</italic> and for which a biochemical record is available.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Gene name</th><th align="left" valign="bottom" rowspan="1" colspan="1">Protein name</th><th align="left" valign="bottom" rowspan="1" colspan="1">ALDH family<xref rid="pro70024-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Source</th><th align="left" valign="bottom" rowspan="1" colspan="1">GenBank protein ID</th><th align="left" valign="bottom" rowspan="1" colspan="1">Length</th><th align="left" valign="bottom" rowspan="1" colspan="1">Structure source<xref rid="pro70024-note-0005" ref-type="table-fn">
<sup>b</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Cofactor preference</th><th align="left" valign="bottom" rowspan="1" colspan="1">Oligomerization state</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reference</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">RALDH 1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA51692</td><td align="left" valign="top" rowspan="1" colspan="1">501</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4WJ9" ext-link-type="uri">4WJ9</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Koch et al. (<xref rid="pro70024-bib-0042" ref-type="bibr">2015</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1A2</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">RALDH 2</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">BAA34785</td><td align="left" valign="top" rowspan="1" colspan="1">518</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4X2Q" ext-link-type="uri">4X2Q</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Zhao et al. (<xref rid="pro70024-bib-0093" ref-type="bibr">1996</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1A3</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">RALDH&#x02010;3</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA79036</td><td align="left" valign="top" rowspan="1" colspan="1">512</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=5FHZ" ext-link-type="uri">5FHZ</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Moretti et al. (<xref rid="pro70024-bib-0056" ref-type="bibr">2016</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1B1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1B1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA96830</td><td align="left" valign="top" rowspan="1" colspan="1">517</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P30837&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Stagos et al. (<xref rid="pro70024-bib-0075" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1L1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">FDH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1L</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAC35000</td><td align="left" valign="top" rowspan="1" colspan="1">902</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q3SY69&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH1L2</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">mtFDH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH1L</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAI03935</td><td align="left" valign="top" rowspan="1" colspan="1">923</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q3SY69&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Strickland et al. (<xref rid="pro70024-bib-0079" ref-type="bibr">2011</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH2</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH&#x02010;E2</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA51693</td><td align="left" valign="top" rowspan="1" colspan="1">517</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=1O05" ext-link-type="uri">1O05</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Hurley et al. (<xref rid="pro70024-bib-0032" ref-type="bibr">2001</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH3A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDHIII</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA51696</td><td align="left" valign="top" rowspan="1" colspan="1">453</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=3SZA" ext-link-type="uri">3SZA</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Hsu et al. (<xref rid="pro70024-bib-0030" ref-type="bibr">1992</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH3A2</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">FALDH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAB01003</td><td align="left" valign="top" rowspan="1" colspan="1">485</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4QGK" ext-link-type="uri">4QGK</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Kelson et al. (<xref rid="pro70024-bib-0038" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH3B1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3B1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA83428</td><td align="left" valign="top" rowspan="1" colspan="1">468</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P43353&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Kitamura et al. (<xref rid="pro70024-bib-0041" ref-type="bibr">2013</xref>) and Marchitti et al. (<xref rid="pro70024-bib-0052" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH3B2</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3B2</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAA85441</td><td align="left" valign="top" rowspan="1" colspan="1">385</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P48448&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH4A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">P5CDH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH4</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAC50501</td><td align="left" valign="top" rowspan="1" colspan="1">563</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=3V9G" ext-link-type="uri">3V9G</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Srivastava et al. (<xref rid="pro70024-bib-0074" ref-type="bibr">2012</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH5A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Hs</italic>SSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAA72076</td><td align="left" valign="top" rowspan="1" colspan="1">535</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2W8O" ext-link-type="uri">2W8O</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Kim et al. (<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>), this study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH6A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">MMSDH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH6</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAB76468</td><td align="left" valign="top" rowspan="1" colspan="1">535</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q02252&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH7A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Alpha&#x02010;AASA</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH7</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">NP_001173</td><td align="left" valign="top" rowspan="1" colspan="1">539</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4ZVX" ext-link-type="uri">4ZVX</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Brocker et al. (<xref rid="pro70024-bib-0008" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH8A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH8A1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH8</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAG42417</td><td align="left" valign="top" rowspan="1" colspan="1">487</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q9H2A2&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Hsu et al. (<xref rid="pro70024-bib-0029" ref-type="bibr">1999</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH9A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH9A1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH9</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAF43600</td><td align="left" valign="top" rowspan="1" colspan="1">494</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=6QAP" ext-link-type="uri">6QAP</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Kikonyogo and Pietruszko (<xref rid="pro70024-bib-0039" ref-type="bibr">1996</xref>) and Koncitikova et al. (<xref rid="pro70024-bib-0043" ref-type="bibr">2019</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH16A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH16A1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH16</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAH14895</td><td align="left" valign="top" rowspan="1" colspan="1">802</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q8IZ83&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">ALDH18A1</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">P5CS</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH18</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Homo sapiens</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAA64224</td><td align="left" valign="top" rowspan="1" colspan="1">795</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2H5G" ext-link-type="uri">2H5G</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">AD(T)P</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Hu et al. (<xref rid="pro70024-bib-0031" ref-type="bibr">1999</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD1</td><td align="left" valign="top" rowspan="1" colspan="1">mtGabD1</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Mycobacterium tuberculosis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">WP_003912534</td><td align="left" valign="top" rowspan="1" colspan="1">457</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P9WNX9&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">de Carvalho et al. (<xref rid="pro70024-bib-0015" ref-type="bibr">2011</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">SySSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Synechocystis</italic> 6803</td><td align="left" valign="top" rowspan="1" colspan="1">BAA10090</td><td align="left" valign="top" rowspan="1" colspan="1">454</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q55585&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Ito and Osanai (<xref rid="pro70024-bib-0033" ref-type="bibr">2020</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">SpSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pyogenes</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">WP_014407552</td><td align="left" valign="top" rowspan="1" colspan="1">465</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4OGD" ext-link-type="uri">4OGD</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Jang et al. (<xref rid="pro70024-bib-0035" ref-type="bibr">2014</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">BsSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">NP_388273</td><td align="left" valign="top" rowspan="1" colspan="1">462</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P94428&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)/ NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Park et al. (<xref rid="pro70024-bib-0064" ref-type="bibr">2014</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">DmSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Drosophila melanogaster</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">NP_651408</td><td align="left" valign="top" rowspan="1" colspan="1">509</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q9VBP6&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Rothacker and Ilg (<xref rid="pro70024-bib-0069" ref-type="bibr">2008</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">AbSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Acinetobacter baumanii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">ANA38811</td><td align="left" valign="top" rowspan="1" colspan="1">482</td><td align="left" valign="top" rowspan="1" colspan="1">AF</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Phonbuppha et al. (<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SYNPCC7002_A2771</td><td align="left" valign="top" rowspan="1" colspan="1">SySSADH_2</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Synechococcus</italic> sp. PCC 7002</td><td align="left" valign="top" rowspan="1" colspan="1">WP_012308363</td><td align="left" valign="top" rowspan="1" colspan="1">454</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=4IT9" ext-link-type="uri">4IT9</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Park and Rhee (<xref rid="pro70024-bib-0063" ref-type="bibr">2013</xref>) and Zhang and Liu (<xref rid="pro70024-bib-0092" ref-type="bibr">2015</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">yneI</td><td align="left" valign="top" rowspan="1" colspan="1">StSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Salmonella typhimurium</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">WP_000178397</td><td align="left" valign="top" rowspan="1" colspan="1">462</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=3ETF" ext-link-type="uri">3ETF</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H) more than NADP<sup>+</sup> (H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer (Tetramer at high concentration)</td><td align="left" valign="top" rowspan="1" colspan="1">Zhang and Liu (<xref rid="pro70024-bib-0092" ref-type="bibr">2015</xref>) and Zheng et al. (<xref rid="pro70024-bib-0094" ref-type="bibr">2013</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALDH5F1</td><td align="left" valign="top" rowspan="1" colspan="1">SSADH1</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Arabidopsis thaliana</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAF23590</td><td align="left" valign="top" rowspan="1" colspan="1">528</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q9SAK4&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Busch and Fromm (<xref rid="pro70024-bib-0009" ref-type="bibr">1999</xref>) and Toyokura et al. (<xref rid="pro70024-bib-0086" ref-type="bibr">2011</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">all3556</td><td align="left" valign="top" rowspan="1" colspan="1">ApSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Anabaena</italic> sp. PCC7120</td><td align="left" valign="top" rowspan="1" colspan="1">BAB75255</td><td align="left" valign="top" rowspan="1" colspan="1">455</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q8YR92&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Wang et al. (<xref rid="pro70024-bib-0089" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">CySSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Cyanothece</italic> sp. ATCC51142</td><td align="left" valign="top" rowspan="1" colspan="1">ACB53576</td><td align="left" valign="top" rowspan="1" colspan="1">455</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;B1WSJ7&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Xie et al. (<xref rid="pro70024-bib-0090" ref-type="bibr">2020</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gabD</td><td align="left" valign="top" rowspan="1" colspan="1">EcGabDSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAC36831</td><td align="left" valign="top" rowspan="1" colspan="1">482</td><td align="left" valign="top" rowspan="1" colspan="1">PDB: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=3JZ4" ext-link-type="uri">3JZ4</ext-link>
</td><td align="left" valign="top" rowspan="1" colspan="1">NADP<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Ahn et al. (<xref rid="pro70024-bib-0002" ref-type="bibr">2010</xref>), Cozzani et al. (<xref rid="pro70024-bib-0014" ref-type="bibr">1980</xref>), and Donnelly and Cooper (<xref rid="pro70024-bib-0020" ref-type="bibr">1981</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">sad yneI</td><td align="left" valign="top" rowspan="1" colspan="1">EcYnelSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">Other SSADHs</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">AAC74598</td><td align="left" valign="top" rowspan="1" colspan="1">462</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P76149&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H) more than NADP<sup>+</sup> (H)</td><td align="left" valign="top" rowspan="1" colspan="1">Dimer</td><td align="left" valign="top" rowspan="1" colspan="1">Donnelly and Cooper (<xref rid="pro70024-bib-0020" ref-type="bibr">1981</xref>) and Fuhrer et al. (<xref rid="pro70024-bib-0025" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UGA2</td><td align="left" valign="top" rowspan="1" colspan="1">ScSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">Saccharomyces cerevisiae</td><td align="left" valign="top" rowspan="1" colspan="1">CAA84943</td><td align="left" valign="top" rowspan="1" colspan="1">497</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;P38067&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Cao et al. (<xref rid="pro70024-bib-0011" ref-type="bibr">2014</xref>) and Langendorf et al. (<xref rid="pro70024-bib-0045" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ssadh</td><td align="left" valign="top" rowspan="1" colspan="1">LcSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Lucilia cuprina</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAP78905</td><td align="left" valign="top" rowspan="1" colspan="1">507</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;B0JFD4&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Rothacker et al. (<xref rid="pro70024-bib-0070" ref-type="bibr">2008</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ssadh</td><td align="left" valign="top" rowspan="1" colspan="1">CfSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Ctenocephalides felis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAP78907</td><td align="left" valign="top" rowspan="1" colspan="1">509</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;B0JFD6&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Rothacker et al. (<xref rid="pro70024-bib-0070" ref-type="bibr">2008</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ASPNIDRAFT_57046</td><td align="left" valign="top" rowspan="1" colspan="1">AnSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus niger</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">EHA20532</td><td align="left" valign="top" rowspan="1" colspan="1">531</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;G3Y8S4&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Kumar et al. (<xref rid="pro70024-bib-0044" ref-type="bibr">2015</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aldh5a1</td><td align="left" valign="top" rowspan="1" colspan="1">MmSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Mus musculus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">BAC35105</td><td align="left" valign="top" rowspan="1" colspan="1">523</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q8BWF0&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H)</td><td align="left" valign="top" rowspan="1" colspan="1">Tetramer</td><td align="left" valign="top" rowspan="1" colspan="1">Rivett and Tipton (<xref rid="pro70024-bib-0068" ref-type="bibr">1981</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AGABI1DRAFT_113228</td><td align="left" valign="top" rowspan="1" colspan="1">AgbSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Agaricus bisporus Lge</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">EKM79984</td><td align="left" valign="top" rowspan="1" colspan="1">528</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;K5VZN4&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NAD<sup>+</sup>(H) more than NADP<sup>+</sup> (H)</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Baldy (<xref rid="pro70024-bib-0005" ref-type="bibr">1977</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">lmo0913</td><td align="left" valign="top" rowspan="1" colspan="1">LmSSADH</td><td align="left" valign="top" rowspan="1" colspan="1">ALDH5 (Human&#x02010;like SSADHs)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Listeria monocytogenes</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">CAC98991</td><td align="left" valign="top" rowspan="1" colspan="1">488</td><td align="left" valign="top" rowspan="1" colspan="1">AFDB: AF&#x02010;Q8Y8I9&#x02010;F1</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Feehily et al. (<xref rid="pro70024-bib-0023" ref-type="bibr">2013</xref>)</td></tr></tbody></table><table-wrap-foot id="pro70024-ntgp-0002"><fn id="pro70024-note-0003"><p>Abbreviations: AF, predicted with AlphaFold2 in this work by using Colabfold scripts (<ext-link xlink:href="https://github.com/sokrypton/ColabFold)" ext-link-type="uri">https://github.com/sokrypton/ColabFold</ext-link>); AFDB, obtained from AlphaFold&#x02010;EBI protein structure database (<ext-link xlink:href="https://alphafold.ebi.ac.uk/" ext-link-type="uri">https://alphafold.ebi.ac.uk/</ext-link>) with the ID reported; PDB, obtained from Protein Data Bank (<ext-link xlink:href="https://www.rcsb.org/" ext-link-type="uri">https://www.rcsb.org/</ext-link>) with the ID reported; NA, not available.</p></fn><fn id="pro70024-note-0004"><label>
<sup>a</sup>
</label><p>The classification of ALDH families is based on Vasiliou and Nebert (<xref rid="pro70024-bib-0088" ref-type="bibr">2005</xref>), while the distinction between &#x0201c;Human&#x02010;like&#x0201d; or &#x0201c;Other&#x0201d; SSADHs is based on the evolutionary analyses presented in this study.</p></fn><fn id="pro70024-note-0005"><label>
<sup>b</sup>
</label><p>Source of protein structures used for building the alignment used for the phylogeny in Figure&#x000a0;<xref rid="pro70024-fig-0001" ref-type="fig">1</xref>.</p></fn></table-wrap-foot></table-wrap><p>In the present work, we initially carried out an evolutionary investigation of the SSADH class of enzymes, determining the phylogenetic relationships of hSSADH and other SSADHs or human ALDHs and highlighting the phylogenetic traits conserved in human&#x02010;like SSADHs. Second, a deep characterization of the spectroscopic and kinetic properties of WT hSSADH was accomplished and the molecular basis for catalytic competence was proposed by investigating spectroscopic and kinetic features of variants of ionizable active site residues suggested to be highly conserved in human&#x02010;like SSADHs. Overall, we suggested that, at least for hSSADH, efficient catalysis is controlled by a network of active site residues in contact with the two catalytic ones (Cys340 and Glu306). This analysis could ultimately pave the way for the interpretation of the loss&#x02010;of&#x02010;function of SSADH pathogenic variants affecting not only the active site but also the intricate network of interactions shaping it.</p></sec><sec id="pro70024-sec-0002"><label>2</label><title>RESULTS AND DISCUSSION</title><sec id="pro70024-sec-0003"><label>2.1</label><title>Known <styled-content style="fixed-case" toggle="no">SSADHs</styled-content> belong to two deeply divergent evolutionary groups with differences in the oligomerization state and in the network of conserved active site residues</title><p>Given the large number of available SSADH and SSADH&#x02010;like sequences, an evolutionary&#x02010;bioinformatic analysis could provide relevant information regarding residues responsible for oligomeric assembly, active site organization, and cofactor preference of hSSADH. This information could also be valuable in identifying the molecular rationale of SSADH activity in pathogenic variants. Therefore, we studied the evolution of biochemical and structural properties of characterized SSADHs in the sequence space of the ALDH superfamily.</p><p>Sequence similarity networks (Figure&#x000a0;<xref rid="pro70024-fig-0001" ref-type="fig">1a</xref>) built at a minimum 40% global pairwise sequence identity (a threshold commonly used for discriminating between ALDH families; Vasiliou and Nebert&#x000a0;<xref rid="pro70024-bib-0088" ref-type="bibr">2005</xref>) suggest that SSADHs belong to two different paralogue families, referred in this study as the <italic toggle="yes">ALDH5</italic>, which includes hSSADH, and <italic toggle="yes">Other SSADHs</italic>. The first one includes SSADHs from Eukaryotes (including hSSADH) and from some bacterial species (<italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Acinetobacter baumanii</italic>, <italic toggle="yes">Listeria monocytogenes</italic>, <italic toggle="yes">Bacillus subtilis</italic>; Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>), usually annotated as the &#x0201c;gabD&#x0201d; paralogue gene of <italic toggle="yes">E. coli</italic> (Fuhrer et al.&#x000a0;<xref rid="pro70024-bib-0025" ref-type="bibr">2007</xref>), while the second includes only bacterial SSADHs usually annotated as the &#x0201c;yneI&#x0201d; paralogue gene of <italic toggle="yes">E. coli</italic>.</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0001"><label>FIGURE 1</label><caption><p>Diversity and evolution of SSADHs within ALDH superfamily and maximum likelihood unrooted phylogenetic tree of characterized SSADHs and ALDHs coded by human genes. (a) Sequence similarity networks (SSNs) of ALDH superfamily homologous to human ALDHs or characterized SSADHs from non&#x02010;human organisms. See the text for info on how the sequences were collected. The edge&#x02010;weighted spring embedded layout with respect to the edge weights was used for visualization. A dashed blue circle highlights the region of the sequence space encompassing nodes that have a minimum of 45% sequence identity to hSSADH. (b) See Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref> for details on sequence identifiers. The structures used for aligning the sequences are from PDB, AlphaFold&#x02010;EBI protein structure database (<ext-link xlink:href="https://alphafold.ebi.ac.uk/" ext-link-type="uri">https://alphafold.ebi.ac.uk/</ext-link>) or predicted with AF2; info reported in Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>. The branch length is proportional to the expected substitution rate, according to the reference bar. Only nodes with bootstrap support &#x0003c;97 are labeled.</p></caption><graphic xlink:href="PRO-34-e70024-g010" position="anchor" id="jats-graphic-5"/></fig><p>The phylogenetic analysis confirmed that both SSADH families are monophyletic, with <italic toggle="yes">ALDH5s</italic> closely related to other tetrameric ALDHs, while <italic toggle="yes">Other SSADHs</italic> members are related to dimeric ALDHs (Figure&#x000a0;<xref rid="pro70024-fig-0001" ref-type="fig">1b</xref>). We retrieved representative sequences of each SSADH family (2191 for the <italic toggle="yes">ALDH5</italic> and 3011 for the <italic toggle="yes">Other SSADH</italic>) to gain insight on this structural difference and additional features, through the analysis of taxonomy, coevolution, and the conservation of critical active site residues. A clear difference in the taxonomic distribution is evident: only the <italic toggle="yes">ALDH5</italic> family contains sequences from Eukaryota (i.e., Metazoa, Fungi, Viridiplantae), while the <italic toggle="yes">Other SSADH</italic> family essentially contains members from Eubacteria and Archea (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2a</xref>). The large fraction of taxonomically unassigned metagenomic samples in both families was not considered in this analysis.</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0002"><label>FIGURE 2</label><caption><p>Evolutionary comparison of representative sequences from <italic toggle="yes">ALDH5</italic> and <italic toggle="yes">Other SSADH</italic> families. (a) Taxonomy distribution of the source organisms for each SSADH family. (b) Box plot of evolutionary coupling (EC) scores (see section&#x000a0;<xref rid="pro70024-sec-0009" ref-type="sec">4</xref>) for each residue pair predicted to interact at oligomeric interfaces in hSSADH simulations (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>). DI, residue pairs at dimeric interface; TI, residue pairs at tetrameric interface; Backbone, EC scores of residue pairs interacting by backbone atoms; Sidechain, EC scores of residue pairs interacting by sidechain atoms. (c) Frequency logo of catalytic and titratable residues of hSSADH within representative sequences of the two SSADHs families. (d) hSSADH active site with the catalytic Cys340 manually deprotonated (PDB ID: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2W8O" ext-link-type="uri">2W8O</ext-link>). NAD<sup>+</sup> and SSA were fully flexible docked with DynamicBind v.1.0 (plDDT<sub>SSA</sub>&#x02009;&#x02248;&#x02009;0.75, plDDT<sub>NAD</sub>
<sup>+</sup>&#x02009;&#x02248;&#x02009;0.69; see section&#x000a0;<xref rid="pro70024-sec-0009" ref-type="sec">4</xref>) and visualized in ball&#x02010;and&#x02010;sticks together with catalytic and titratable active site residues. Black dashed lines connect the sulfur atom of the catalytic Cys340 to the reactive carbon centers of NAD<sup>+</sup> and SSA.</p></caption><graphic xlink:href="PRO-34-e70024-g002" position="anchor" id="jats-graphic-7"/></fig><p>We used direct coupling analysis on alignments of representative sequences of both families to analyze the evolutionary coupling scores (EC scores, corresponding to co&#x02010;evolutionary signals). Residues that formed stable non&#x02010;covalent interchain contacts over molecular dynamics (MD) simulations replicates of the hSSADH tetramer were considered (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref> and Figure&#x000a0;<xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S1</xref>). While there is an equal number of high EC scores between residues corresponding to dimeric contacts in both <italic toggle="yes">SSADH</italic> and <italic toggle="yes">ALDH5</italic> families, high EC scores corresponding to residues at the tetrameric interface were inferred only for the <italic toggle="yes">ALDH5</italic> family (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2b</xref>). As expected, interfacial residues showed a high positive EC score usually only when interacting by side chain atoms, while residue pairs interacting through backbone atoms showed very low EC scores, both at the dimeric and tetrameric interface. We further tested if the presence of differently distributed co&#x02010;evolutionary information in the alignments could also impact the Alpha&#x02010;Fold (AF) template&#x02010;free modeling capacity of a tetrameric assembly of hSSADH, using either the <italic toggle="yes">ALDH5</italic> or the <italic toggle="yes">Other SSADH</italic> alignments as inputs. Predicted interfacial structural quality scores (iPTM score)&#x02009;&#x0003e;&#x02009;0.75 usually result in correctly modeled interfaces. We obtained an iPTM&#x02009;&#x0003e;&#x02009;0.9 at dimeric interfaces for most of the models produced using both alignments. On the contrary, the iPTM scores at tetrameric interfaces were &#x0003e;0.9 only for models that used the alignment of sequences from <italic toggle="yes">ALDH5</italic> family, while it was significantly lower (&#x0003c;0.437) for most of the models produced from sequences from the <italic toggle="yes">Other SSADH</italic> family. Overall, the performed analyses suggested that (i) during the evolution of interfacial residues, a strong co&#x02010;evolutionary constraint is present when interfacial interactions need to preserve amino acid type (reflected by its side chain), while residues interacting through backbone are apparently less constrained, as also observed in Hockenberry and Wilke (<xref rid="pro70024-bib-0028" ref-type="bibr">2019</xref>); (ii) the co&#x02010;evolutionary signals at the tetrameric interface suggest that most, if not all, <italic toggle="yes">ALDH5s</italic> are tetrameric, while <italic toggle="yes">Other SSADHs</italic> are mostly if not all, dimeric. Importantly, several kinetic and modeling studies on the SSADH reaction mechanism were performed on bacterial SSADHs belonging to the dimeric family (SySSADH and StSSADH; Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>). This highlights the need to perform a detailed functional investigation on the human enzyme, for which significant differences are expected.</p><p>Interestingly, residues Arg173, Gly176, and Gly533 at the dimeric and/or tetrameric interface (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>) are substituted in SSADH deficiency (due to missense mutations in <italic toggle="yes">ALDH5A1</italic>) and their pathogenicity was associated with a folding/oligomerization failure (Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0085" ref-type="bibr">2023c</xref>).</p><p>Previous studies identified catalytically important residues of hSSADH (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>): the catalytic pair Cys340 and Glu306, and the residues Arg213, Arg334, and Ser498, essential for SSA binding. By inspecting the active site of the crystal structure of the oxidized form of hSSADH (PDB ID: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2W8O" ext-link-type="uri">2W8O</ext-link>; Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2d</xref>) two additional titratable residues, Lys214 and Glu515, interacting with Glu306, were identified. These residues could participate in modulating the protonation state of the latter residue. Among the conserved residues, it is interesting to note that only Cys340, Glu306, Glu515, Arg213, and Ser498 are conserved among all SSADHs, while Cys342, Lys214, and Arg334 are conserved only in the <italic toggle="yes">ALDH5</italic> family (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2c</xref>). This indicates that the SSADHs which possess a single cysteine at the active site and the ones that have two active site cysteine residues (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>) belong to two distinct families and, besides a similar general mechanism and the possibility to oxidize the same substrate, they may display profound differences in their kinetic properties and a diverse substrate preference consistent with the usually broad substrate specificity observed in <italic toggle="yes">Other SSADHs</italic> (Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>). Despite such distinct patterns of conservation of the active site, the cofactor preference is not phylogenetically clustered (Figure&#x000a0;<xref rid="pro70024-fig-0001" ref-type="fig">1b</xref>). All eukaryotic <italic toggle="yes">ALDH5s</italic> have high affinity only for NAD<sup>+</sup>, while prokaryotic <italic toggle="yes">ALDH5</italic> and most of <italic toggle="yes">Other SSADHs</italic> prefer NADP<sup>+</sup> or have promiscuous affinity for both cofactors. Since a switch between NAD<sup>+</sup> and NADP<sup>+</sup> preference requires only a few amino acid substitutions (Jang et al.&#x000a0;<xref rid="pro70024-bib-0035" ref-type="bibr">2014</xref>; Yuan et al.&#x000a0;<xref rid="pro70024-bib-0091" ref-type="bibr">2013</xref>), we suggest that this feature is not phylogenetically grounded, but it has been tweaked with respect to the type of cofactor used in redox reactions in different taxa and subcellular compartments (i.e., in eukaryotic mitochondria NAD<sup>+</sup> is used and NADP<sup>+</sup> is absent; Stein and Imai&#x000a0;<xref rid="pro70024-bib-0076" ref-type="bibr">2012</xref>).</p><p>Based on the in silico information about differences between SSADHs belonging to different phylogenetic groups, we designed a detailed investigation of the main structural and functional properties of hSSADH.</p></sec><sec id="pro70024-sec-0004"><label>2.2</label><title>Catalysis of purified recombinant <styled-content style="fixed-case" toggle="no">hSSADH</styled-content> proceeds through an ordered bi&#x02013;bi mechanism and is regulated by <styled-content style="fixed-case" toggle="no">SSA</styled-content> concentration</title><p>The stable and active tetrameric hSSADH has been expressed and purified as described (Didiasova et al.&#x000a0;<xref rid="pro70024-bib-0018" ref-type="bibr">2024</xref>) and its spectroscopic properties have been determined (for details see Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>, Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S2</xref>, and Figures&#x000a0;<xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S2a&#x02013;d</xref>, <xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S3</xref>, and <xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S4</xref>). Since the kinetic features of hSSADH have not been previously investigated in detail, we carried out a functional characterization.</p><p>The determination of the kinetic parameters of the reaction catalyzed by hSSADH was a complex task due to the partial non&#x02010;competitive inhibition exerted by the substrate SSA (Figure&#x000a0;<xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S5</xref>). Overall, data indicate a behavior compatible with an ordered bi&#x02013;bi mechanism, with NAD<sup>+</sup> binding first to the enzyme (Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>, Figures&#x000a0;<xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S6</xref> and <xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S7</xref>, and Tables&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S3</xref> and <xref rid="pro70024-tbl-0002" ref-type="table">2</xref>), a kinetic mechanism shared with several aldehyde dehydrogenases (Munoz&#x02010;Clares and Casanova&#x02010;Figueroa&#x000a0;<xref rid="pro70024-bib-0057" ref-type="bibr">2019</xref>). We determined the most reliable estimate for <italic toggle="yes">k</italic>
<sub>cat</sub> (about 160&#x02013;170&#x02009;s<sup>&#x02212;1</sup>) at 25&#x000b0;C, while <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> values for both cosubstrates and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">i</italic>
</sub> for SSA were determined at a lower temperature (14&#x000b0;C) to slow down the reaction rate (Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref> and Table&#x000a0;<xref rid="pro70024-tbl-0002" ref-type="table">2</xref>). These analyses resulted in the determination of <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>SSA</sub>&#x02009;=&#x02009;1.2&#x02009;&#x000b1;&#x02009;0.2&#x02009;&#x003bc;M and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>NAD+</sub>&#x02009;=&#x02009;31&#x02009;&#x000b1;&#x02009;5&#x02009;&#x003bc;M, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">i</italic>SSA</sub>&#x02009;=&#x02009;13&#x02009;&#x000b1;&#x02009;3&#x02009;&#x003bc;M. Table&#x000a0;<xref rid="pro70024-tbl-0002" ref-type="table">2</xref> summarizes the values of kinetic parameters determined under different experimental conditions to reach the best estimates.</p><table-wrap position="float" id="pro70024-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Determination of the kinetic parameters of the reaction of hSSADH by fitting data to different models.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">From Dixon plots (25&#x000b0;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">From Equation&#x000a0;(<xref rid="pro70024-disp-0003" ref-type="disp-formula">3</xref>) (25&#x000b0;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">From Equation&#x000a0;(<xref rid="pro70024-disp-0004" ref-type="disp-formula">4</xref>) (25&#x000b0;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">From Equation&#x000a0;(<xref rid="pro70024-disp-0005" ref-type="disp-formula">5</xref>) (25&#x000b0;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">From Equation&#x000a0;(<xref rid="pro70024-disp-0005" ref-type="disp-formula">5</xref>) (14&#x000b0;C)</th></tr></thead><tbody valign="top"><tr><td rowspan="3" align="left" valign="top" colspan="1">Subinhibitory (SSA)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">k</italic>
<sub>cat</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">80&#x02009;&#x000b1;&#x02009;10&#x02009;s<sup>&#x02212;1</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">87&#x02009;&#x000b1;&#x02009;4&#x02009;s<sup>&#x02212;1</sup>
</td><td rowspan="3" align="left" valign="top" colspan="1"/><td rowspan="3" align="left" valign="top" colspan="1"/><td rowspan="3" align="left" valign="top" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>SSA</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.6&#x02009;&#x000b1;&#x02009;0.2&#x02009;&#x003bc;M</td><td align="left" valign="top" rowspan="1" colspan="1">1.5&#x02009;&#x000b1;&#x02009;0.2&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>NAD+</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">14&#x02009;&#x000b1;&#x02009;8&#x02009;&#x003bc;M</td><td align="left" valign="top" rowspan="1" colspan="1">36&#x02009;&#x000b1;&#x02009;5&#x02009;&#x003bc;M</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">Inhibitory (SSA)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">k</italic>
<sub>cat</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">165&#x02009;&#x000b1;&#x02009;23&#x02009;s<sup>&#x02212;1</sup>
</td><td rowspan="6" align="left" valign="top" colspan="1"/><td rowspan="6" align="left" valign="top" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>SSA</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>NAD+</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">32&#x02009;&#x000b1;&#x02009;12&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">is</italic>
</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">5&#x02009;&#x000b1;&#x02009;3&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">ix</italic>
</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">84&#x02009;&#x000b1;&#x02009;12&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">ii</italic>
</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7&#x02009;&#x000b1;&#x02009;2&#x02009;&#x003bc;M</td></tr><tr><td rowspan="5" align="left" valign="top" colspan="1">Full range (SSA)</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">k</italic>
<sub>cat</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">166&#x02009;&#x000b1;&#x02009;33&#x02009;s<sup>&#x02212;1</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">26&#x02009;&#x000b1;&#x02009;2&#x02009;s<sup>&#x02212;1</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>SSA</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4&#x02009;&#x000b1;&#x02009;1&#x02009;&#x003bc;M</td><td align="left" valign="top" rowspan="1" colspan="1">1.2&#x02009;&#x000b1;&#x02009;0.2&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>NAD+</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">84&#x02009;&#x000b1;&#x02009;23&#x02009;&#x003bc;M</td><td align="left" valign="top" rowspan="1" colspan="1">31&#x02009;&#x000b1;&#x02009;5&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">i</italic>SSA</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">9&#x02009;&#x000b1;&#x02009;3&#x02009;&#x003bc;M</td><td align="left" valign="top" rowspan="1" colspan="1">13&#x02009;&#x000b1;&#x02009;3&#x02009;&#x003bc;M</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">b</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.030&#x02009;&#x000b1;&#x02009;0.008</td><td align="left" valign="top" rowspan="1" colspan="1">0.06&#x02009;&#x000b1;&#x02009;0.01</td></tr></tbody></table></table-wrap><p>Given the competitive inhibition of NADH with respect to NAD<sup>+</sup> (see Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>), the partial non&#x02010;competitive component of the SSA inhibition could be due to its combination in a dead&#x02010;end fashion with the complex E&#x02010;NADH (Scheme&#x000a0;<xref rid="pro70024-fig-0010" ref-type="fig">3</xref>), in analogy to what already observed for other aldehyde dehydrogenases with partial substrate inhibition (Munoz&#x02010;Clares and Casanova&#x02010;Figueroa&#x000a0;<xref rid="pro70024-bib-0057" ref-type="bibr">2019</xref>).</p><fig position="float" fig-type="SCHEME" id="pro70024-fig-0010"><label>SCHEME 3</label><caption><p>Proposed reaction mechanism for hSSADH. NAD<sup>+</sup> binds first to the enzyme followed by SSA with the formation of the ternary complex. This then releases the SA and NADH products (straight lines). At high SSA concentrations, a partial non&#x02010;competitive inhibition exerted by SSA occurs, with the formation of a partial inhibitory ternary complex E&#x02010;SSA&#x02010;NADH. The reduced cofactor is then replaced by NAD<sup>+</sup> to regenerate the catalytically competent ternary complex E&#x02010;SSA&#x02010;NAD<sup>+</sup> (dashed lines). This outlined mechanism is based on extensive investigations previously reported for other aldehyde dehydrogenases that show a substrate (aldehyde) partial inhibition behavior similar to that of hSSADH (Munoz&#x02010;Clares and Casanova&#x02010;Figueroa&#x000a0;<xref rid="pro70024-bib-0057" ref-type="bibr">2019</xref>).</p></caption><graphic xlink:href="PRO-34-e70024-g003" position="anchor" id="jats-graphic-9"/></fig><p>It should be noted that values of Michaelis&#x02013;Menten and inhibition constants for SSA are in a low micromolar range. Thus, the effects exerted by the aldehyde could be relevant even at physiological concentrations. In addition, hSSADH exhibits a turnover rate (see above) far exceeding the values previously reported (Chambliss et al.&#x000a0;<xref rid="pro70024-bib-0012" ref-type="bibr">1995</xref>; Chambliss and Gibson&#x000a0;<xref rid="pro70024-bib-0013" ref-type="bibr">1992</xref>; Kang et al.&#x000a0;<xref rid="pro70024-bib-0037" ref-type="bibr">2005</xref>). As an example, rat SSADH exhibits a lower <italic toggle="yes">k</italic>
<sub>cat</sub> (Murphy et al.&#x000a0;<xref rid="pro70024-bib-0059" ref-type="bibr">2003</xref>), as well as SSADHs present in various organisms (Cao et al.&#x000a0;<xref rid="pro70024-bib-0011" ref-type="bibr">2014</xref>; Jang et al.&#x000a0;<xref rid="pro70024-bib-0035" ref-type="bibr">2014</xref>; Park et al.&#x000a0;<xref rid="pro70024-bib-0064" ref-type="bibr">2014</xref>; Park and Rhee&#x000a0;<xref rid="pro70024-bib-0063" ref-type="bibr">2013</xref>; Zheng et al.&#x000a0;<xref rid="pro70024-bib-0094" ref-type="bibr">2013</xref>), with the exception of the NADP<sup>+</sup> dependent <italic toggle="yes">Acinobacter baumanii</italic> SSADH (Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>). This discrepancy is in line with the fact that previous kinetic analyses in those papers were carried out without considering the whole range of cosubstrate concentrations, as instead suggested for aldehyde dehydrogenases by Munoz&#x02010;Clares and Casanova&#x02010;Figueroa (<xref rid="pro70024-bib-0057" ref-type="bibr">2019</xref>).</p><p>Stopped&#x02010;flow pre&#x02010;steady state kinetics shows a burst of NADH formation in 15&#x02013;20&#x02009;ms before reaching the turnover steady&#x02010;state (Figure&#x000a0;<xref rid="pro70024-fig-0003" ref-type="fig">3</xref>). This implies that hydride transfer from the hemiacetal to the cofactor is faster than the following steps of deacylation and product release. The amount of NADH produced in the burst phase linearly correlates with the enzyme concentration (Figure&#x000a0;<xref rid="pro70024-fig-0003" ref-type="fig">3</xref>, inset), suggesting that all enzyme active sites fully accomplish the reaction. This differs from what reported in <italic toggle="yes">Acinobacter baumanii</italic> SSADH (Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>) where only a small percentage of active sites are active.</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0003"><label>FIGURE 3</label><caption><p>Burst kinetics and active site titration of hSSADH. Reactions were carried out at 20&#x02009;&#x003bc;M SSA and 500&#x02009;&#x003bc;M NAD<sup>+</sup> by adding the following hSSADH concentrations: 4&#x02009;&#x003bc;M (black), 8&#x02009;&#x003bc;M (red), 10&#x02009;&#x003bc;M (blue), 12&#x02009;&#x003bc;M (green), and 14&#x02009;&#x003bc;M (pink). The absorbance change at 340&#x02009;nm was monitored using a stopped&#x02010;flow spectrophotometer at 4&#x000b0;C in 100&#x02009;mM potassium phosphate buffer, 10&#x02009;mM BME at pH&#x02009;8. The inset shows the correlation of the concentration of NADH formed during the burst phase with hSSADH concentration.</p></caption><graphic xlink:href="PRO-34-e70024-g006" position="anchor" id="jats-graphic-11"/></fig></sec><sec id="pro70024-sec-0005"><label>2.3</label><title>The <styled-content style="fixed-case" toggle="no">SSADH</styled-content>&#x02010;<styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup> complex stabilizes <styled-content style="fixed-case" toggle="no">hSSADH</styled-content> and protects the catalytic Cys340</title><p>We carried out the spectroscopic characterization (by circular dichroism, absorbance and fluorescence emission) of WT hSSADH in the absence and in the presence of NAD<sup>+</sup> to reveal spectral perturbation following the binding of the cofactor. This information is critical when dealing with variants (including the pathogenic ones) that could result in the alteration of cofactor binding both in terms of affinity and/or of microenvironment modifications.</p><p>The far UV circular dichroism (CD) spectrum of 2&#x02009;&#x003bc;M hSSADH (the concentration is always reported as the monomer concentration, unless for kinetic assays since the active functional enzyme species is the tetramer) presents two negative (208 and 222&#x02009;nm) and one positive (195&#x02009;nm) bands typical of a high &#x003b1;&#x02010;helical content protein (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4a</xref>). Deconvolution of the spectrum reveals a 29.7% of &#x003b1;&#x02010;helix and 29.9% of &#x003b2;&#x02010;strand structures content. Overall, these values are in agreement with the ones determined from the analysis of the crystal structure: 37% of &#x003b1;&#x02010;helix and 27.6% of &#x003b2;&#x02010;strand structures (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>). The presence of 100&#x02009;&#x003bc;M NAD<sup>+</sup> produces minor modifications in the far UV signals with a modest decrease in &#x003b1;&#x02010;helix content (24.9%) and an almost identical &#x003b2;&#x02010;structure percentage (29.6%). This is reminiscent of the effects observed upon the binding of NAD<sup>+</sup> to other dehydrogenases (Murtas et al.&#x000a0;<xref rid="pro70024-bib-0060" ref-type="bibr">2021</xref>).</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0004"><label>FIGURE 4</label><caption><p>Spectral characterization of WT hSSADH. All spectra were collected in 100&#x02009;mM potassium phosphate buffer, 10&#x02009;mM BME at pH&#x02009;8 at 25&#x000b0;C. (a) Far UV CD spectra of 2&#x02009;&#x003bc;M (monomer concentration) WT hSSADH in the absence (black line) or presence of 100&#x02009;&#x003bc;M NAD<sup>+</sup> (red line). (b) Near UV&#x02013;visible spectra of 18&#x02009;&#x003bc;M WT hSSADH in the absence (black line) or presence (blue line) of 200&#x02009;&#x003bc;M NAD<sup>+</sup>. (c) Absorbance spectra of 18&#x02009;&#x003bc;M WT hSSADH in the absence (black line) or presence (blue line) of 200&#x02009;&#x003bc;M NAD<sup>+</sup>. (d) Plot of the quenching in intrinsic fluorescence spectra of 0.1&#x02009;&#x003bc;M WT hSSADH in the presence of different concentrations of NAD<sup>+</sup>. Data were fitted to a hyperbola equation to obtain the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> value. Inset: Intrinsic fluorescence spectra of 0.1&#x02009;&#x003bc;M WT hSSADH (black line) in the presence of different concentrations of NAD<sup>+</sup> (0.1&#x02009;&#x003bc;M, red; 0.5&#x02009;&#x003bc;M, dark green; 1&#x02009;&#x003bc;M, orange; 4&#x02009;&#x003bc;M, blue; 8&#x02009;&#x003bc;M, gray; 20&#x02009;&#x003bc;M, purple; 50&#x02009;&#x003bc;M, light green; 75&#x02009;&#x003bc;M, pink; and 100&#x02009;&#x003bc;M, brown). The arrow indicates the change at increasing cofactor concentrations.</p></caption><graphic xlink:href="PRO-34-e70024-g005" position="anchor" id="jats-graphic-13"/></fig><p>Binding of NAD<sup>+</sup> results in a ~4&#x000b0;C increase in <italic toggle="yes">T</italic>
<sub>
<italic toggle="yes">m</italic>
</sub>, as determined by thermal denaturation at 222&#x02009;nm by CD spectroscopy and by differential scanning calorimetry (DSC) (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S4</xref>), suggesting that NAD<sup>+</sup> binding confers higher thermal stability. On the other hand, the presence of a reducing agent does not seem to significantly influence thermal stability, suggesting that disulfide bonds do not play a major role in protein stabilization (see Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>).</p><p>The near&#x02010;UV visible CD spectrum of 18&#x02009;&#x003bc;M hSSADH shows two positive peaks at 284 and 291&#x02009;nm, in addition to small negative signals in the region around 265&#x02009;nm, attributable to the aromatic residues of the enzyme (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4b</xref>). NAD<sup>+</sup> binding (200&#x02009;&#x003bc;M) leads to the appearing of a strong negative signal centered at 315&#x02009;nm (not due to free NAD<sup>+</sup> in solution) and to a modification in the region of the aromatic amino acids of SSADH (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4b</xref>). These spectral changes are suggestive of a binding, resulting in the positioning of the cofactor in an asymmetric microenvironment. The formation of hSSADH&#x02010;NAD<sup>+</sup> complex is also observed by absorbance spectral analysis where binding of NAD<sup>+</sup> results in the formation of a broad shoulder at 320&#x02009;nm (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4c</xref>). This absorbance behavior, reported for some SSADH enzymes in the presence of their cofactor, was interpreted as the formation of a covalent complex (Paladkong et al.&#x000a0;<xref rid="pro70024-bib-0062" ref-type="bibr">2022</xref>; Park and Rhee&#x000a0;<xref rid="pro70024-bib-0063" ref-type="bibr">2013</xref>). Finally, the intensity of intrinsic protein fluorescence (excitation at 295&#x02009;nm, emission at 335&#x02009;nm) is quenched in the presence of NAD<sup>+</sup> due to internal energy transfer, thus further supporting a tight binding of the cofactor to the enzyme (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4d</xref>, inset). Altogether, NAD<sup>+</sup> binding can be clearly followed by CD, absorbance or fluorescence spectroscopy, and results in a thermal stabilization of hSSADH.</p><p>The equilibrium dissociation constant of NAD<sup>+</sup> has been measured by evaluating the decrease of the emission band at 335&#x02009;nm (<italic toggle="yes">&#x003bb;</italic>
<sub>exc</sub> 295&#x02009;nm) following the addition of increasing concentrations of NAD<sup>+</sup> to 0.1&#x02009;&#x003bc;M hSSADH (for details see Materials and methods section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>). The plot of the quenching variations as a function of NAD<sup>+</sup> concentration was fitted to a hyperbola equation resulting in a <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub>&#x02009;=&#x02009;4.5&#x02009;&#x000b1;&#x02009;0.8&#x02009;&#x003bc;M (Figure&#x000a0;<xref rid="pro70024-fig-0004" ref-type="fig">4d</xref>). The fact that SSADH could covalently and reversibly bind NAD<sup>+</sup> (independently of SSA) has been proposed to be a protective mechanism to avoid hyperoxidation of the catalytic active site Cys340, as suggested not only for a bacterial <italic toggle="yes">Acinobacter baumanii</italic> SSADH, but also for other aldehyde dehydrogenases (Munoz&#x02010;Clares et al.&#x000a0;<xref rid="pro70024-bib-0058" ref-type="bibr">2017</xref>; Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>). The cofactor binding should proceed through a nucleophilic attack of the catalytic Cys thiolate to the C4 atom of the NAD<sup>+</sup> nicotinamide ring. This covalent bond reversibly dissociates in the presence of SSA (Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>). This can be the case also for hSSADH and is corroborated by the higher affinity of SSA with respect to NAD<sup>+</sup>. Thus, the formation of the binary complex between the enzyme and the NAD<sup>+</sup> cofactor could be regarded as a shielding strategy to limit the accessibility to the catalytic Cys340 by oxidizing agents.</p></sec><sec id="pro70024-sec-0006"><label>2.4</label><title>Acid&#x02013;base groups govern catalysis and <styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup> equilibrium binding</title><p>We determined the value of <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> for NAD<sup>+</sup> as a function of pH in 50&#x02009;mM Bis&#x02010;Tris&#x02010;Propane (BTP) given its wide buffering range. At pH&#x02009;8 the measured <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> value is nearly similar (2.1&#x02009;&#x000b1;&#x02009;0.4&#x02009;&#x003bc;M) to the one evaluated in potassium phosphate buffer. The dissociation constant for NAD<sup>+</sup> decreases at increasing pH values, indicating an affinity increase, possibly due to the deprotonation of a residue with a pK<sub>a</sub> of 6.36&#x02009;&#x000b1;&#x02009;0.06 (Figure&#x000a0;<xref rid="pro70024-fig-0005" ref-type="fig">5</xref>).</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0005"><label>FIGURE 5</label><caption><p>Dependence of <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub> on pH. All measurements were performed in 50&#x02009;mM BTP and 10&#x02009;mM BME at the indicated pH values. At each pH value, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub> was obtained by measuring the quenching of intrinsic fluorescence determined by exciting 0.1&#x02009;&#x003bc;M WT hSSADH (black), 0.1&#x02009;&#x003bc;M Lys214Ala (blue), 0.1&#x02009;&#x003bc;M Glu515Ala (green), and 0.4&#x02009;&#x003bc;M Glu306Ala (red) at different NAD<sup>+</sup> concentrations (from 0.1 to 100&#x02009;&#x003bc;M) and fitting the data to a hyperbolic equation. The pK<sub>a</sub> determination was obtained by fitting the resulting <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> values to Equation&#x000a0;(<xref rid="pro70024-disp-0006" ref-type="disp-formula">6</xref>).</p></caption><graphic xlink:href="PRO-34-e70024-g004" position="anchor" id="jats-graphic-15"/></fig><p>Furthermore, we determined the kinetic parameters of the reaction as a function of pH for both cosubstrates (see section&#x000a0;<xref rid="pro70024-sec-0009" ref-type="sec">4</xref>). The resulting kinetic parameters were plotted as log <italic toggle="yes">k</italic>
<sub>cat</sub> or log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> for both cosubstrates versus pH. The plots of log <italic toggle="yes">k</italic>
<sub>cat</sub> for both SSA and NAD<sup>+</sup> exhibit an increase in the acidic range which reaches a plateau above pH ~8 (Figure&#x000a0;<xref rid="pro70024-fig-0006" ref-type="fig">6a,b</xref>). Data were fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0007" ref-type="disp-formula">7</xref>) yielding a pK<sub>a</sub> value of ~6.5&#x02013;7 that could be attributed to the protonation state of the enzyme&#x02013;cosubstrates catalytic complex. Since the same pK<sub>a</sub> is also found in the log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> plot (fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0008" ref-type="disp-formula">8</xref>) and Figure&#x000a0;<xref rid="pro70024-fig-0006" ref-type="fig">6c,d</xref>), it can be reasonably attributed to an enzyme residue involved in catalysis. The second pK<sub>a</sub> (~9.5) obtained in the bell&#x02010;shaped dependence of log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> plot could be attributed to either an enzyme or a substrate group involved in catalysis or binding. All pK<sub>a</sub> values are reported in Table&#x000a0;<xref rid="pro70024-tbl-0003" ref-type="table">3</xref>. Interestingly, the pK<sub>a</sub> affecting NAD<sup>+</sup> affinity is in the same range as the acidic catalytic pK<sub>a</sub>.</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0006"><label>FIGURE 6</label><caption><p>Dependence of kinetic parameters on pH. Kinetic parameters were determined at the following pH values: 5.4, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, and 10.0. All measurements were performed in 50&#x02009;mM BTP and 10&#x02009;mM BME at the indicated pH values. Log <italic toggle="yes">k</italic>
<sub>cat</sub> for NAD<sup>+</sup> (a) and for SSA (b) versus pH, as well as Log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> for NAD<sup>+</sup> (c) and for SSA (d) versus pH were determined and fitted to Equations&#x000a0;(<xref rid="pro70024-disp-0007" ref-type="disp-formula">7</xref>) and (<xref rid="pro70024-disp-0008" ref-type="disp-formula">8</xref>), respectively.</p></caption><graphic xlink:href="PRO-34-e70024-g008" position="anchor" id="jats-graphic-17"/></fig><table-wrap position="float" id="pro70024-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>pKa values for the kinetic parameters of the reaction.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">pKa1</th><th align="left" valign="bottom" rowspan="1" colspan="1">pKa2</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">log <italic toggle="yes">k</italic>
<sub>cat</sub> SSA</td><td align="left" valign="top" rowspan="1" colspan="1">6.9&#x02009;&#x000b1;&#x02009;0.1</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>SSA</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">6.8&#x02009;&#x000b1;&#x02009;0.1</td><td align="left" valign="top" rowspan="1" colspan="1">9.7&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">log <italic toggle="yes">k</italic>
<sub>cat</sub> NAD<sup>+</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">6.9&#x02009;&#x000b1;&#x02009;0.1</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">log <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>NAD+</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">6.6&#x02009;&#x000b1;&#x02009;0.2</td><td align="left" valign="top" rowspan="1" colspan="1">9.2&#x02009;&#x000b1;&#x02009;0.2</td></tr></tbody></table><table-wrap-foot id="pro70024-ntgp-0003"><fn id="pro70024-note-0006"><p>
<italic toggle="yes">Note</italic>: Experiments were carried out in 50&#x02009;mM BTP at pH values from 5.5 to 10 at 25&#x000b0;C.</p></fn></table-wrap-foot></table-wrap><p>Attributing the obtained pK<sub>a</sub> values to specific enzyme groups is rather challenging. The pK<sub>a</sub> in the basic region, visible only in the <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> plots, most likely reflects a basic group of the enzyme that needs to be protonated to efficient catalysis and/or binding. Two basic residues (Arg213 and Arg334) are present at the active site and are involved, together with Ser498, in an electrostatic/H&#x02010;bonding network with the carboxy moiety of SSA (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>). Arg213 is at 4.1&#x02009;&#x000c5; from the carboxy group of the catalytic Glu306 in the reduced SSADH form, and at 4.2&#x02009;&#x000c5; from the same group in the structure solved in the presence of SSA (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2d</xref>). These distances are compatible with a strong electrostatic interaction. Thus, we suggest that the basic pK<sub>a</sub> could be attributed to one or both of these Arg residues, engaged in an extensive network at the active site, playing a crucial role in binding the SSA substrate.</p><p>The attribution of the acidic pK<sub>a</sub> of ~6.5&#x02013;7, present in the plots of the dependence of the kinetic parameters and the NAD<sup>+</sup>
<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub>, needed more consideration.</p><p>First, based on literature, bioinformatic predictions (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S5</xref>) and knowledge regarding this class of enzymes, we proposed the catalytic Glu306 as the most probable candidate. Its carboxylate is positioned at 3.8&#x02009;&#x000c5; from the catalytic Cys340 to accomplish its acid&#x02013;base role in catalysis (deprotonation and reprotonation steps; Scheme&#x000a0;<xref rid="pro70024-fig-0009" ref-type="fig">2</xref>) and forms the thiolate group able to perform a nucleophilic attack on a suitable electrophile (either NAD<sup>+</sup> or the carbonyl of SSA). Moreover, the bacterial <italic toggle="yes">Acinobacter baumanii</italic> SSADH presents a kinetic and titration pK<sub>a</sub> of ~7.5, suggested to be responsible for the formation of the thiolate state of the catalytic cysteine (Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>). However, in that paper, the observed pK<sub>a</sub> was attributed to either the catalytic glutamate or to the catalytic cysteine itself (Phonbuppha et al.&#x000a0;<xref rid="pro70024-bib-0065" ref-type="bibr">2018</xref>) without discriminating among them.</p><p>Considering this conflicting attribution, reinforced by the fact that for most of the aldehyde dehydrogenases the catalytic cysteine residue is reluctant to deprotonation (Munoz&#x02010;Clares et al.&#x000a0;<xref rid="pro70024-bib-0058" ref-type="bibr">2017</xref>), we deepened our investigation. The prediction of pK<sub>a</sub> values of cysteine residues is subject to potential overestimation with a variance of &#x0003e;2&#x02009;pK<sub>a</sub> units (Awoonor&#x02010;Williams et al.&#x000a0;<xref rid="pro70024-bib-0004" ref-type="bibr">2023</xref>). This depends on the fact that the actual pK<sub>a</sub> of catalytic cysteine residues could be decreased by the network of H&#x02010;bonds established by the sulfur atom and/or by amide nitrogen of the nearby peptide bonds (Marchal and Branlant&#x000a0;<xref rid="pro70024-bib-0051" ref-type="bibr">1999</xref>). A mutational study on the bacterial <italic toggle="yes">A. baumanii</italic> SSADH suggested that the second Cys (of the CXC motif; Munoz&#x02010;Clares et al.&#x000a0;<xref rid="pro70024-bib-0058" ref-type="bibr">2017</xref>) could be responsible for lowering the pK<sub>a</sub> of the catalytic cysteine (Paladkong et al.&#x000a0;<xref rid="pro70024-bib-0062" ref-type="bibr">2022</xref>). However, hSSADH Cys342Ala variant was shown to catalyze the dehydrogenase reaction efficiently and even more rapidly at the same pH value as the WT (Kim et al.&#x000a0;<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>), ruling out that, at least in these experimental conditions, Cys342 may play a major role. Notably, the microenvironment of Cys340 shows that a salt bridge between Lys214 and Glu515 causes the carboxylate of the latter residue to be in proximity to the carboxylate of Glu306 (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2d</xref>). Considering that Lys214 is highly conserved in ALDH5 family, it could be essential in maintaining the correct orientation of the Glu515 side&#x02010;chain to tackle Glu306, and, in turn, Cys340.</p></sec><sec id="pro70024-sec-0007"><label>2.5</label><title>The active site <styled-content style="fixed-case" toggle="no">hSSADH</styled-content> variants reveal the structural determinants for the interconnected bond network ensuring efficient catalysis</title><p>A mutagenic study was performed on the catalytic residues and the above listed second&#x02010;shell titratable active site residues of hSSADH, to define which ones could be directly or indirectly associated with the acidic pK<sub>a</sub> value(s) observed in both hSSADH kinetics and in the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub> pH profiles.</p><p>Cys340Ala, Cys340Ser, Glu306Ala, Glu306Gln, Glu515Ala, Glu515Gln, and Lys214Ala variants have been expressed, purified, and characterized, showing no relevant structural changes or microenvironment alterations with respect to the WT (Results section in Data&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S1</xref>, Tables&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S6</xref> and <xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S7</xref>, and Figure&#x000a0;<xref rid="pro70024-supitem-0001" ref-type="supplementary-material">S8a&#x02013;c</xref>).</p><p>Substitutions of first&#x02010;shell catalytic residues Glu306 and Cys340 result in almost inactive variants (&#x02264;0.1% residual activity in comparison to the WT). In addition, Cys340 variants were unable to bind NAD<sup>+</sup>, while Glu306 variants displayed a different behavior: Glu306Ala presents a strongly reduced affinity for the cofactor (&#x0003e;10&#x02010;fold increased <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub>), while the conservative Glu306Gln has a cofactor affinity similar to that of the WT (4.3&#x02009;&#x000b1;&#x02009;0.4&#x02009;&#x003bc;M vs. 4.5&#x02009;&#x000b1;&#x02009;0.8&#x02009;&#x003bc;M, respectively) (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S6</xref>). The fact that NAD<sup>+</sup> still binds to Glu306 variants could reflect the presence of a small proportion of Cys340 thiolate that is however unable to undergo the acid/base catalysis.</p><p>Substitutions of second&#x02010;shell residues Lys214 and Glu515 resulted in variants retaining only 1.2% and 1.3% residual activity for Lys214Ala and Glu515Ala, respectively. The conservative substitution Glu515Gln had only a moderate effect on activity (residual activity &#x02248;66%). Both residues Lys214 and Glu515 (Figure&#x000a0;<xref rid="pro70024-fig-0002" ref-type="fig">2d</xref>) participate in the stabilization of the network of weak interactions with Cys340 and NAD<sup>+</sup>, thus playing an essential role in NAD<sup>+</sup> binding and in the chemical step of catalysis.</p><p>Ala&#x02010;substitutions result in the loss of the salt bridge between Lys214 and Glu515 and/or loss of H&#x02010;bonds essential to establish a crucial interaction with Glu306. It is conceivable that this perturbation could alter the pK<sub>a</sub> of Glu306 side chain (Scheme&#x000a0;<xref rid="pro70024-fig-0009" ref-type="fig">2</xref>). If the proton flow is impaired, catalysis proceeds slowly. Actually, for both variants, the initial reaction rates are insensitive to pH under the same assay conditions (10&#x02009;&#x003bc;M SSA, 500&#x02009;&#x003bc;M NAD<sup>+</sup>) (Figure&#x000a0;<xref rid="pro70024-fig-0007" ref-type="fig">7</xref>) (with a slight increase for Lys214Ala at basic pH values), thus corroborating an effect on Glu306.</p><fig position="float" fig-type="FIGURE" id="pro70024-fig-0007"><label>FIGURE 7</label><caption><p>Dependence of activity on pH for active SSADH variants. Activity was determined by measuring the formation of NADH (see section&#x000a0;<xref rid="pro70024-sec-0009" ref-type="sec">4</xref> for details) obtained by incubating 8&#x02009;nM WT (black), or 0.1&#x02009;&#x003bc;M Glu515Ala (green), or 0.35&#x02009;&#x003bc;M Lys214Ala (blue) with 10&#x02009;&#x003bc;M SSA and 500&#x02009;&#x003bc;M NAD<sup>+</sup>. The amount of NADH produced was expressed as micromol/sec/micromol of tetrameric enzyme (v<sub>0</sub>).</p></caption><graphic xlink:href="PRO-34-e70024-g007" position="anchor" id="jats-graphic-19"/></fig><p>As for NAD<sup>+</sup> binding, Lys214Ala showed an affinity higher than WT, possibly due to the increase in hydrophobicity of the active site pocket (the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub> for this variant was 2.5&#x02009;&#x000b1;&#x02009;0.2&#x02009;&#x003bc;M at pH&#x02009;8). On the other hand, both variants at position Glu515 showed a large decrease (~4&#x02010; to 9&#x02010;fold) in the affinity for cofactor (Table&#x000a0;<xref rid="pro70024-supitem-0002" ref-type="supplementary-material">S6</xref>) under the same experimental conditions. This could indicate an alteration of the relative orientation of Cys340/nicotinamide ring, as suggested by spectroscopic signals.</p><p>The pH dependence of the affinity constant for the cofactor for all Ala&#x02010;substituted Lys214, Glu306, and Glu515 residues of the active site network are independent of pH (with a slight increase at basic pH for Lys214Ala) except for Glu306Ala whose affinity constant shows a pK<sub>a</sub>&#x02009;=&#x02009;6.6&#x02009;&#x000b1;&#x02009;0.4, similar to that of the WT (Figure&#x000a0;<xref rid="pro70024-fig-0005" ref-type="fig">5</xref>). This suggests that the observed pK<sub>a</sub> of ~6.5&#x02013;7 of WT (also present in the log <italic toggle="yes">k</italic>
<sub>cat</sub> plot) is not attributable to Glu306. Thus, the Lys214&#x02010;Glu515 dyad could be the only suitable candidate responsible for the acidic pK<sub>a</sub> of ~6.5&#x02013;7.</p><p>Overall, a complex network at the enzyme active site is responsible for the protonation state of Cys340. The (second&#x02010;shell) Lys214&#x02010;Glu515 dyad appears to play two crucial roles: first, in the absence of the substrate SSA, they keep Cys340 thiolate prone to covalently bind NAD<sup>+</sup> as a protective mechanism against hyperoxidation of hSSADH. This represents a new additional protective mechanism to the one based on the formation of a disulfide bond with Cys342 reported by Kim et al. (<xref rid="pro70024-bib-0040" ref-type="bibr">2009</xref>). Glu306 does not play any substantial role in this latter control mechanism. Second, in the presence of SSA, the networked dyad provides Glu306 with the correct protonation state to abstract/donate protons to Cys340, thus enhancing catalysis. Any factors altering these connections are predicted to impact hSSADH activity. It follows that SSADH deficiency pathogenic variants that affect, directly or indirectly, these network elements would cause loss&#x02010;of&#x02010;function.</p></sec></sec><sec sec-type="conclusions" id="pro70024-sec-0008"><label>3</label><title>CONCLUSIONS</title><p>We showed that the thiolate state of the hSSADH catalytic Cys340, unlike other aldehyde dehydrogenases (Munoz&#x02010;Clares et al.&#x000a0;<xref rid="pro70024-bib-0058" ref-type="bibr">2017</xref>), is mainly controlled at physiological conditions by a network of coordinated bonds and is protected from oxidation by the formation of a reversible adduct with its cofactor. Since the concentration of NAD<sup>+</sup> in cells is 0.2&#x02013;0.5&#x02009;mM (Canto et al.&#x000a0;<xref rid="pro70024-bib-0010" ref-type="bibr">2015</xref>), which is considerably higher than the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> of this hSSADH&#x02010;NAD<sup>+</sup> binary complex, it can be argued that hSSADH mainly exists NAD<sup>+</sup>&#x02010;bound. When SSA enters the active site, NAD<sup>+</sup> is displaced from Cys340 which performs a nucleophilic attack on the substrate aldehyde that has an affinity higher (about 1&#x02009;&#x003bc;M) than NAD<sup>+</sup>, as extrapolated by the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>SSA</sub> value. The complex reaction mechanism and the non&#x02010;competitive partial inhibition by SSA are described here. Given the low micromolar range of the SSA inhibition constant, this can be of physiological significance.</p><p>A regulatory mechanism of catalysis as well as of NAD<sup>+</sup> binding is played by a network of residues, among which Glu515 seems to play a pivotal role. Data suggest that the acidic pK<sub>a</sub> in both kinetic and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> plots can be attributable to the intricate network (involving Lys214 and Glu306) that sustains Glu515. Its correct protonation state is mandatory to maintain the catalytic Glu306 deprotonated at physiological pH, so that it can act on Cys340 to trigger catalysis. At the same time, it directly controls cofactor binding and thiolate protection even in the absence of Glu306. The in silico analysis further suggests that such a complex network may be specific to the ALDH5 family, to which hSSADH belongs, and can be a shared feature for the whole family.</p><p>This combinatory approach underlines that catalysis is finely tuned not only by the catalytic residues responsible for the chemistry of the reaction but also by a second shell of residues responsible for regulating the catalytic ones. Thus, the subtle interactions among first&#x02010;shell catalytic residues and second&#x02010;shell networked residues might play the main role in hSSADH catalysis and/or oxidative insult protection. These findings are also potentially crucial to finding the rationale of the molecular basis for the pathogenicity of several SSADH deficiency variants, directly or indirectly influencing the identified active site network. From this study, the pathogenic effect of some variants of residues involved in interface stabilization (Arg173, Gly176, and Gly533), NAD<sup>+</sup> binding (Gly268) and catalysis (Asn335) (Tokatly Latzer et al.&#x000a0;<xref rid="pro70024-bib-0085" ref-type="bibr">2023c</xref>) can be interpreted by small local changes that trigger wider consequences in a sort of <italic toggle="yes">domino</italic> effect that ultimately affect the active site architecture. This widens the possibility of defining a precision therapy approach based on the knowledge of each structural determinant that governs the total or partial loss&#x02010;of&#x02010;function.</p></sec><sec sec-type="materials-and-methods" id="pro70024-sec-0009"><label>4</label><title>MATERIALS AND METHODS</title><sec sec-type="materials" id="pro70024-sec-0010"><label>4.1</label><title>Materials</title><p>SSA, SA, NAD<sup>+</sup>, NADH, dithiothreitol (DTT), thrombin, &#x003b2;&#x02010;mercaptoethanol (BME), isopropyl&#x02010;&#x003b2;&#x02010;d&#x02010;thiogalactopyranoside (IPTG), phenylmethylsulfonyl fluoride (PMSF), and SigmaFast inhibitor cocktail were purchased from Merck (Darmstadt, Germany). Anti&#x02010;SSADH and anti&#x02010;His&#x02010;tag antibodies were from Santa Cruz Biotechnology (Dallas, TX). All other chemicals were of the highest purity available.</p></sec><sec id="pro70024-sec-0011"><label>4.2</label><title>Determination of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">K</italic>
<sub>
<italic toggle="no">D</italic>
</sub>
</styled-content> for <styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup>
</title><p>The equilibrium dissociation binding constant, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub>, for NAD<sup>+</sup> was determined by following the change in the intrinsic fluorescence (<italic toggle="yes">&#x003bb;</italic>
<sub>exc</sub>&#x02009;=&#x02009;295&#x02009;nm, <italic toggle="yes">&#x003bb;</italic>
<sub>em</sub>&#x02009;=&#x02009;335&#x02009;nm) of 0.1&#x02009;&#x003bc;M enzymatic species (except for Glu306Ala whose concentration was set to 0.4&#x02009;&#x003bc;M), measured by increasing NAD<sup>+</sup> concentrations (0.1&#x02013;100&#x02009;&#x003bc;M). The changes in fluorescence quenching were plotted versus NAD<sup>+</sup> concentrations and the data were fitted to a hyperbola equation to obtain the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> value.</p></sec><sec id="pro70024-sec-0012"><label>4.3</label><title>Determination of the steady state kinetic parameters, of the reaction mechanism and active site titration</title><p>Steady state kinetic parameters have been obtained by incubating 8&#x02009;nM SSADH with increasing concentrations of SSA (from 1 to 200&#x02009;&#x003bc;M) and of NAD<sup>+</sup> (from 1 to 1500&#x02009;&#x003bc;M) in 100&#x02009;mM potassium phosphate buffer, pH&#x02009;8 at 25&#x000b0;C. Initial rates were determined by following spectrophotometrically the signal of increase of NADH at 340&#x02009;nm (<italic toggle="yes">&#x003b5;</italic>
<sub>
<italic toggle="yes">M</italic>
</sub>&#x02009;=&#x02009;6.22&#x02009;mM<sup>&#x02212;1</sup>&#x02009;cm<sup>&#x02212;1</sup>). The same assay was carried out at 14&#x000b0;C in the presence of 2&#x02009;nM SSADH and different concentrations of the cosubstrates (0.2&#x02013;500&#x02009;&#x003bc;M SSA and 5&#x02013;500&#x02009;&#x003bc;M NAD<sup>+</sup>), by evaluating the concentration of NADH produced by exciting at 340&#x02009;nm and measuring the change in fluorescence intensity at 445&#x02009;nm. A calibration curve has been built correlating the change in fluorescence intensity to the concentration of NADH.</p><p>The obtained plots were fitted to the Michaelis&#x02013;Menten equation (Equation&#x000a0;(<xref rid="pro70024-disp-0001" ref-type="disp-formula">1</xref>)) to determine the apparent value of the kinetic parameters for both cosubstrates at subinhibitory SSA concentrations (1&#x02013;10&#x02009;&#x003bc;M), or to the Michaelis&#x02013;Menten equation corrected for substrate inhibition when SSA was assayed at different concentrations (Equation&#x000a0;(<xref rid="pro70024-disp-0002" ref-type="disp-formula">2</xref>)), where <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> represents the apparent affinity constant for SSA and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">i</italic>
</sub> the apparent SSA inhibitory constant.<disp-formula id="pro70024-disp-0001">
<label>(1)</label>
<mml:math id="jats-math-1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>app</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mi>max</mml:mi></mml:msub><mml:mo>&#x02219;</mml:mo><mml:mfenced open="[" close="]"><mml:mi>S</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>app</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced open="[" close="]"><mml:mi>S</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="pro70024-disp-0002">
<label>(2)</label>
<mml:math id="jats-math-2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>app</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mi>max</mml:mi></mml:msub><mml:mo>&#x02219;</mml:mo><mml:mfenced open="[" close="]"><mml:mi>S</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>app</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced open="[" close="]"><mml:mi>S</mml:mi></mml:mfenced><mml:mspace width="0.25em"/><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mfenced open="[" close="]"><mml:mi>S</mml:mi></mml:mfenced><mml:msub><mml:mrow><mml:mi>app</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Global fitting of all data collected at subinhibitory SSA concentrations and full&#x02010;range NAD<sup>+</sup> concentrations were then fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0003" ref-type="disp-formula">3</xref>) which accounts for an ordered bi&#x02013;bi mechanism,<disp-formula id="pro70024-disp-0003">
<label>(3)</label>
<mml:math id="jats-math-3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>max</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced></mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="italic">iA</mml:mi></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <italic toggle="yes">A</italic> is the first substrate to bind to the enzyme, <italic toggle="yes">B</italic> is the second substrate and the one that exhibits substrate inhibition, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">A</italic>
</sub> and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">B</italic>
</sub> are the Michaelis constants for substrate <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, respectively, and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">iA</italic>
</sub> is the dissociation constant of <italic toggle="yes">A</italic> from its complex with the enzyme.</p><p>In the presence of inhibitory SSA concentrations (from 12 to 200&#x02009;&#x003bc;M), data were fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0004" ref-type="disp-formula">4</xref>),<disp-formula id="pro70024-disp-0004">
<label>(4)</label>
<mml:math id="jats-math-4" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>max</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="italic">ix</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mtext mathvariant="italic">is</mml:mtext></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="italic">ii</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <italic toggle="yes">A</italic> is the first substrate to bind to the enzyme, <italic toggle="yes">B</italic> is the second substrate and the one that exhibits substrate inhibition, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">A</italic>
</sub> is the Michaelis constants for substrate <italic toggle="yes">A</italic>, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">is</italic>
</sub> is the slope inhibition constant and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">ix</italic>
</sub> and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">ii</italic>
</sub> are intercepts inhibition constants.</p><p>Equation&#x000a0;(<xref rid="pro70024-disp-0005" ref-type="disp-formula">5</xref>) was used for global fitting at full range concentrations of cosubstrates for a partial non&#x02010;competitive substrate inhibition simulation,<disp-formula id="pro70024-disp-0005">
<label>(5)</label>
<mml:math id="jats-math-5" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>max</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mi>b</mml:mi><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced></mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mtext mathvariant="italic">is</mml:mtext></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="italic">iA</mml:mi></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="[" close="]"><mml:mi>A</mml:mi></mml:mfenced><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mfenced open="[" close="]"><mml:mi>B</mml:mi></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mtext mathvariant="italic">is</mml:mtext></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <italic toggle="yes">A</italic> is the first substrate to bind to the enzyme, <italic toggle="yes">B</italic> is the second substrate and the one that exhibits substrate inhibition, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">A</italic>
</sub> and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">B</italic>
</sub> are the Michaelis constants for substrates <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, respectively, <italic toggle="yes">b</italic> is the factor that describes the effect of substrate inhibition on <italic toggle="yes">V</italic>
<sub>max</sub>, <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">is</italic>
</sub> is the substrate inhibition constant affecting the slope and <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">iA</italic>
</sub> is the dissociation constant of <italic toggle="yes">A</italic> from its complex with the enzyme. With this fitting, the estimate of the latter parameter (<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">iA</italic>
</sub> is <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>NAD+</sub>) is rough, while it was better measured by spectroscopic analyses (see above).</p><p>Product inhibition studies have been carried out by using different concentrations of NADH (from 17 to 220&#x02009;&#x003bc;M) keeping SSA saturating (10&#x02009;&#x003bc;M) at variable NAD<sup>+</sup> concentrations. The obtained plots were fitted to linear regression curves that converged on the y&#x02010;axis, indicative of a competitive inhibition. Values of slopes and intercepts were plotted for <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">i</italic>
</sub> determination. Inhibition by 55&#x02009;&#x003bc;M NADH is fitted to a competitive or non&#x02010;competitive model at the different combinations (subsaturating or saturating) of cosubstrate concentrations.</p><p>Active site titration was performed by adding different enzyme concentrations (4&#x02013;14&#x02009;&#x003bc;M) to a mixture containing 20&#x02009;&#x003bc;M SSA and 500&#x02009;&#x003bc;M NAD<sup>+</sup>. The absorbance changes at 340&#x02009;nm were monitored at 4&#x000b0;C in 100&#x02009;mM potassium phosphate buffer, 10&#x02009;mM BME at pH&#x02009;8 with a TC10&#x02010;100 (path length of 1&#x02009;cm) quartz cell coupled to a BioKine PMS&#x02010;60 instrument using a stopped&#x02010;flow Biologic SFM300 spectrophotometer.</p></sec><sec id="pro70024-sec-0013"><label>4.4</label><title>
<styled-content style="fixed-case" toggle="no">pH</styled-content> dependence of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">K</italic>
<sub>
<italic toggle="no">D</italic>NAD</sub>
</styled-content>
<sub>+</sub> and of the kinetic parameters</title><p>The determination of the <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> for NAD<sup>+</sup> at various pH values was carried out in 50&#x02009;mM BTP, 10&#x02009;mM BME at the desired pH (range 6&#x02013;10). In details, 0.1&#x02009;&#x003bc;M hSSADH was incubated with different NAD<sup>+</sup> concentrations (0.1&#x02013;100&#x02009;&#x003bc;M) at each pH value and the related <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub> was obtained as reported above. An appropriate blank was run in all experimental conditions and subtracted from samples. Results were fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0006" ref-type="disp-formula">6</xref>) and reported in logarithmic scale to obtain the pK<sub>a</sub>,<disp-formula id="pro70024-disp-0006">
<label>(6)</label>
<mml:math id="jats-math-6" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>C</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">a</mml:mi></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>pH</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <italic toggle="yes">C</italic> represents the pH&#x02010;independent value of <italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">D</italic>
</sub>.</p><p>Kinetic parameters at different pH values were determined by incubating hSSADH (8&#x02009;nM) with increasing concentrations of SSA (from 1 to 200&#x02009;&#x003bc;M) and of NAD<sup>+</sup> (from 1 to 1000&#x02009;&#x003bc;M) in 50&#x02009;mM BTP, 10&#x02009;mM BME, in the pH range 5.5&#x02013;10, at 25&#x000b0;C. Initial rates were determined by the increase of NADH concentration, followed spectrophotometrically at 340&#x02009;nm (<italic toggle="yes">&#x003b5;</italic>
<sub>
<italic toggle="yes">M</italic>
</sub>&#x02009;=&#x02009;6.22&#x02009;mM<sup>&#x02212;1</sup>&#x02009;cm<sup>&#x02212;1</sup>). The values of <italic toggle="yes">k</italic>
<sub>cat</sub> and <italic toggle="yes">k</italic>
<sub>cat</sub>/<italic toggle="yes">K</italic>
<sub>
<italic toggle="yes">m</italic>
</sub> were determined with Equations&#x000a0;(<xref rid="pro70024-disp-0001" ref-type="disp-formula">1</xref>) or (<xref rid="pro70024-disp-0002" ref-type="disp-formula">2</xref>) and plotted versus pH. Kinetic parameters were then fitted to Equation&#x000a0;(<xref rid="pro70024-disp-0007" ref-type="disp-formula">7</xref>) or Equation&#x000a0;(<xref rid="pro70024-disp-0008" ref-type="disp-formula">8</xref>) to obtain the relative pK<sub>a</sub> values,<disp-formula id="pro70024-disp-0007">
<label>(7)</label>
<mml:math id="jats-math-7" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Log</mml:mi><mml:mfenced open="(" close=")"><mml:msub><mml:mi>k</mml:mi><mml:mi>cat</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>Log</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mi>C</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>pH</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="pro70024-disp-0008">
<label>(8)</label>
<mml:math id="jats-math-8" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Log</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mi>cat</mml:mi></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mfrac></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>Log</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mi>C</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>pH</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mi>pH</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <italic toggle="yes">C</italic> is the maximal value observed for the referred parameter.</p></sec><sec id="pro70024-sec-0014"><label>4.5</label><title>Statistical analysis</title><p>Statistical analysis was performed using the GraphPad Prism software (v. 5.02, La Jolla, CA) and OriginPro (v.10.1.0.170, OriginLab, Northampton, MA). The data are presented as mean values&#x02009;&#x000b1;&#x02009;SD unless otherwise stated.</p></sec><sec id="pro70024-sec-0015"><label>4.6</label><title>Sequence similarity networks</title><p>ALDH superfamily was represented by sequence similarity networks (SSNs) around the protein sequences coded by the 19 human ALDH genes. Each human ALDH protein (listed in Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>) was used as query to search other homologous ALDH sequences from the UniRef100 database (03/2021 update), by employing three MMseq2 (release 13&#x02013;45,111) search iterations (Mirdita et al.&#x000a0;<xref rid="pro70024-bib-0055" ref-type="bibr">2019</xref>; Steinegger and Soding&#x000a0;<xref rid="pro70024-bib-0078" ref-type="bibr">2017</xref>). The sequences collected from each query search were filtered by HHfilter 3.3.0 (Steinegger et al.&#x000a0;<xref rid="pro70024-bib-0077" ref-type="bibr">2019</xref>) to allow max 60% pairwise identity and at least 75% alignment coverage to each human ALDH query. The final list consisted of 11,571 ALDH homologous centroid sequences, for which Metadata annotations (i.e., taxonomy) were retrieved from NCBI taxonomy database (Federhen&#x000a0;<xref rid="pro70024-bib-0022" ref-type="bibr">2012</xref>) by <italic toggle="yes">E&#x02010;Utilities</italic> (Sayers&#x000a0;<xref rid="pro70024-bib-0072" ref-type="bibr">2022</xref>). This list of sequences was merged with other 21 proteins for which a biochemical record validating their SSADH activity was available in literature (Table&#x000a0;<xref rid="pro70024-tbl-0001" ref-type="table">1</xref>). The final list of sequences (11,592) was pairwise aligned by Needleman&#x02010;Wunsch algorithm, as implemented in the EMBOSS software suite version 6.6.0 (Rice et al.&#x000a0;<xref rid="pro70024-bib-0067" ref-type="bibr">2000</xref>), using the BLOSUM62 scoring matrix with 10 and 0.5 as gap opening and gap extension penalties, respectively. ALDH SSNs were obtained in GraphML format by NetworkX version 1.9 (Hagberg et al.&#x000a0;<xref rid="pro70024-bib-0027" ref-type="bibr">2008</xref>): each sequence is a node of the network, with edges weighted by % identity, with minimum being 40%, as previously proposed as ALDH inter&#x02010;family threshold (Vasiliou and Nebert&#x000a0;<xref rid="pro70024-bib-0088" ref-type="bibr">2005</xref>). Networks containing only human ALDH or biochemically validated SSADH sequences (3487) were visualized in Cytoscape 3.9.1 (Su et al.&#x000a0;<xref rid="pro70024-bib-0080" ref-type="bibr">2014</xref>) using the Edge&#x02010;Weighted Spring Embedded Layout (Orlando et al.&#x000a0;<xref rid="pro70024-bib-0061" ref-type="bibr">2021</xref>), which places highly interconnected and similar sequences closer in bidimensional space.</p></sec><sec id="pro70024-sec-0016"><label>4.7</label><title>Phylogenetic analysis</title><p>Molecular evolution of SSADHs in the context of ALDH superfamily was studied by estimating a Maximum Likelihood (ML) phylogenetic tree from an alignment of human ALDHs (19) and characterized SSADHs (16) sequences. PhyML 3.3.20211231 (Guindon et al.&#x000a0;<xref rid="pro70024-bib-0026" ref-type="bibr">2010</xref>) was used for 10 ML inference starting from random trees, with LG substitution model (Guindon et al.&#x000a0;<xref rid="pro70024-bib-0026" ref-type="bibr">2010</xref>) and a ML estimate of gamma distribution of site variation (four categories). Bootstrap values at nodes were added by using the gradual transfer distance method from 1000 bootstrap replicates (Lemoine et al.&#x000a0;<xref rid="pro70024-bib-0048" ref-type="bibr">2018</xref>). To generate the input alignment, mTM&#x02010;align (Version 20220104; Dong et al.&#x000a0;<xref rid="pro70024-bib-0019" ref-type="bibr">2018</xref>) was used to make a structure&#x02010;based multiple sequence alignment, using as input the monomeric 3D structures available from PDB and AlphaFold2 pre&#x02010;computed AF models from AlphaFold&#x02010;EBI (accessed at 11/11/2023; Varadi et al.&#x000a0;<xref rid="pro70024-bib-0087" ref-type="bibr">2024</xref>), while the structure was predicted for SSADHs without a PDB record and not in AlphaFold&#x02010;EBI, starting from the raw Uniprot primary sequence. Colabfold v.1.3.0 Jupyter Notebook AlphaFold2_mmseqs2 (<ext-link xlink:href="https://github.com/sokrypton/ColabFold" ext-link-type="uri">https://github.com/sokrypton/ColabFold</ext-link>; Mirdita et al.&#x000a0;<xref rid="pro70024-bib-0054" ref-type="bibr">2022</xref>) was used with default parameters and a final energy minimization step; the structure model with the highest average predicted lDDT score was selected, and residues with predicted lDDT&#x02009;&#x0003c;&#x02009;85 were trimmed. Sites with gaps in more than half of the sequences were removed before proceeding with the phylogenetic inference.</p></sec><sec id="pro70024-sec-0017"><label>4.8</label><title>Direct coupling analysis of <styled-content style="fixed-case" toggle="no">SSADH</styled-content> families</title><p>An SSADH family was defined by inspecting the distribution of characterized SSADHs in SSNs and the phylogenetic tree. A more detailed analysis was performed for each identified SSADH family. Characterized SSADHs from each SSADH family were clustered at 40% identity by CD&#x02010;HIT 4.8.1 to retrieve a per&#x02010;family centroid (Fu et al.&#x000a0;<xref rid="pro70024-bib-0024" ref-type="bibr">2012</xref>). HHblits 3.3.0 (Steinegger et al.&#x000a0;<xref rid="pro70024-bib-0077" ref-type="bibr">2019</xref>) was used to build an alignment of homologous sequences with at least 45% identity and 90% coverage to the centroid sequence of each SSADH family. UniRef100 (<ext-link xlink:href="http://wwwuser.gwdg.de/~compbiol/uniclust/2021_03/" ext-link-type="uri">http://wwwuser.gwdg.de/~compbiol/uniclust/2021_03/</ext-link>) and BFD databases (<ext-link xlink:href="https://bfd.mmseqs.com/" ext-link-type="uri">https://bfd.mmseqs.com/</ext-link>) were employed. To avoid redundancy, the limit of max 90% pairwise identity was allowed. Metadata annotations (i.e., taxonomy) for non&#x02010;metagenomic sequences were retrieved from NCBI taxonomy database (Federhen&#x000a0;<xref rid="pro70024-bib-0022" ref-type="bibr">2012</xref>) by <italic toggle="yes">E&#x02010;Utilities</italic> (Sayers&#x000a0;<xref rid="pro70024-bib-0072" ref-type="bibr">2022</xref>). The family&#x02010;specific alignment was used to investigate the relative frequency of residues at sites important for catalysis and substrate binding in hSSADH, and to infer coevolution signals for residue pairs predicted to interact in hSSADH oligomerization at dimeric and tetrameric interfaces. Coupling scores between any residue pair were estimated by performing a direct coupling analysis with <italic toggle="yes">plmc</italic> (<ext-link xlink:href="https://github.com/debbiemarkslab/plmc" ext-link-type="uri">https://github.com/debbiemarkslab/plmc</ext-link>; Federhen&#x000a0;<xref rid="pro70024-bib-0022" ref-type="bibr">2012</xref>) on the alignment of each SSADH family. Three analyses were performed with different values for the <italic toggle="yes">&#x003b8;</italic> parameter (0, 0.2, 0.3), which defines the minimum relative pairwise sequence difference that is used to down weight similar sequences. The per&#x02010;residue coupling scores for each alignment residue were normalized and averaged over replicates with different <italic toggle="yes">&#x003b8;</italic> parameters. Only scores for residues distant &#x0003e;4 amino acids in the primary sequence were considered in the analysis, to remove any strong co&#x02010;evolutionary signal due to locally conserved functional patterns or secondary structure elements within the same chain.</p></sec><sec id="pro70024-sec-0018"><label>4.9</label><title>Molecular dynamics simulations of tetrameric reduced <styled-content style="fixed-case" toggle="no">hSSADH</styled-content> without <styled-content style="fixed-case" toggle="no">NAD</styled-content>
<sup>+</sup>
</title><p>Five independent molecular dynamics (MD) simulation replicates were performed with GROMACS 2019.6 (Abraham et al.&#x000a0;<xref rid="pro70024-bib-0001" ref-type="bibr">2015</xref>) using the AMBER14SB forcefield (Maier et al.&#x000a0;<xref rid="pro70024-bib-0049" ref-type="bibr">2015</xref>), as follows: the protonation states of <italic toggle="yes">Homo sapiens</italic> SSADH (PDB ID: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2W8O" ext-link-type="uri">2W8O</ext-link>) were determined with respect to the dominant protonation state at pH&#x02009;7.0 according to the predicted pKa (see above). The system was solvated in a dodecahedron box containing TIP3P parameterized explicit water molecules (Jorgensen et al.&#x000a0;<xref rid="pro70024-bib-0036" ref-type="bibr">1983</xref>). Na<sup>+</sup> and Cl<sup>&#x02212;</sup> ions at 100&#x02009;mM concentration were added to neutralize the negative charge of the system. Each system was energy minimized and equilibrated for 4&#x02009;ns in NPT conditions at 298.15&#x02009;K (25&#x000b0;C) (V&#x02010;rescale thermostat) and a constant pressure of 1&#x02009;atm (Berendsen barostat). During equilibration, the positions of heavy atoms were restrained with a force constant of 1000&#x02009;kJ&#x02009;mol<sup>&#x02212;1</sup>&#x02009;nm<sup>&#x02212;1</sup>. Forty nanosecond productive MD simulations were performed for each equilibrated system (integration step of 2&#x02009;fs, Nose&#x02010;Hoover thermostat, and Parrinello&#x02010;Rahman barostat), saving information every 0.1&#x02009;ns. Three MD replicates have converged in the first 20&#x02009;ns and we retained the frames after 20&#x02009;ns for further analyses.</p><p>PyContact (<ext-link xlink:href="https://github.com/maxscheurer/pycontact" ext-link-type="uri">https://github.com/maxscheurer/pycontact</ext-link>; Scheurer et al.&#x000a0;<xref rid="pro70024-bib-0073" ref-type="bibr">2018</xref>) was used to detect non&#x02010;covalent interactions that participate in hSSADH oligomerization, using only interactions at a max distance of 3.6&#x02009;&#x000c5; and present in at least 50% of analyzed simulation frames.</p></sec><sec id="pro70024-sec-0019"><label>4.10</label><title>Flexible induced&#x02010;fit docking of reduced apo <styled-content style="fixed-case" toggle="no">hSSADH</styled-content>
</title><p>The PDB atomic coordinates of reduced hSSADH (PDB ID: <ext-link xlink:href="http://firstglance.jmol.org/fg.htm?mol=2W8O" ext-link-type="uri">2W8O</ext-link>) were docked with NAD<sup>+</sup> (C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N) or SSA (O=CCCC(=O)O). The end&#x02010;to&#x02010;end deep generative method DynamicBind v.1.0 (<ext-link xlink:href="https://doi.org/10.21203/rs.3.rs-3225151/v1" ext-link-type="uri">https://doi.org/10.21203/rs.3.rs-3225151/v1</ext-link>) was used, to allow for full flexibility in the protein and ligand during the docking procedure, which allowed to obtain an induced&#x02010;fit complex. The top&#x02010;1 ranked solution for each docking attempt was retained.</p></sec></sec><sec id="pro70024-sec-0022"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Samuele Cesaro:</bold> Conceptualization; investigation; formal analysis; methodology. <bold>Marco Orlando:</bold> Conceptualization; investigation; writing &#x02013; original draft; methodology; formal analysis. <bold>Ilaria Bettin:</bold> Investigation; methodology; formal analysis. <bold>Carmen Longo:</bold> Investigation; methodology; formal analysis. <bold>Giulia Spagnoli:</bold> Investigation; methodology. <bold>Patrizia Polverino de Laureto:</bold> Investigation; methodology; formal analysis. <bold>Gianluca Molla:</bold> Conceptualization; validation; formal analysis; data curation; supervision. <bold>Mariarita Bertoldi:</bold> Conceptualization; funding acquisition; writing &#x02013; original draft; validation; writing &#x02013; review and editing; supervision; resources; data curation.</p></sec><sec sec-type="COI-statement" id="pro70024-sec-0021"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pro70024-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1.</bold> Supporting Information.</p></caption><media xlink:href="PRO-34-e70024-s002.pptx"/></supplementary-material><supplementary-material id="pro70024-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>Data S1.</bold> Supporting Information.</p></caption><media xlink:href="PRO-34-e70024-s001.docx"/></supplementary-material></sec></body><back><ack id="pro70024-sec-0020"><title>ACKNOWLEDGMENTS</title><p>The authors acknowledge the Centro Piattaforme Tecnologiche (CPT) of the University of Verona for research facilities. This research was supported by grants of the SSADH&#x02010;Defizit e.V. and De Neu Asociacion de Enfermedades de los Neurotrasmisores to MB. Open access publishing facilitated by Universita degli Studi di Verona, as part of the Wiley &#x02010; CRUI&#x02010;CARE agreement.</p></ack><ref-list id="pro70024-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="pro70024-bib-0001"><mixed-citation publication-type="journal" id="pro70024-cit-0001">
<string-name>
<surname>Abraham</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Murtola</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schulz</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pall</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Hess</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>GROMACS: high perfomance molecular simulations through multi&#x02010;levels parallelism from laptops to supercomputers</article-title>. <source>SoftwareX</source>. <year>2015</year>;<volume>1&#x02013;2</volume>:<fpage>7</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0002"><mixed-citation publication-type="journal" id="pro70024-cit-0002">
<string-name>
<surname>Ahn</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YG</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</string-name>. <article-title>Crystal structure of non&#x02010;redox regulated ssadh from <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2010</year>;<volume>392</volume>(<issue>1</issue>):<fpage>106</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">20060383</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0003"><mixed-citation publication-type="journal" id="pro70024-cit-0003">
<string-name>
<surname>Akaboshi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hogema</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Novelletto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Malaspina</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Salomons</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Maropoulos</surname>
<given-names>GD</given-names>
</string-name>, et al. <article-title>Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease&#x02010;causing mutations in patients with SSADH deficiency</article-title>. <source>Hum Mutat</source>. <year>2003</year>;<volume>22</volume>(<issue>6</issue>):<fpage>442</fpage>&#x02013;<lpage>450</lpage>.<pub-id pub-id-type="pmid">14635103</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0004"><mixed-citation publication-type="journal" id="pro70024-cit-0004">
<string-name>
<surname>Awoonor&#x02010;Williams</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Golosov</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Hornak</surname>
<given-names>V</given-names>
</string-name>. <article-title>Benchmarking in silico tools for cysteine pK(a) prediction</article-title>. <source>J Chem Inf Model</source>. <year>2023</year>;<volume>63</volume>(<issue>7</issue>):<fpage>2170</fpage>&#x02013;<lpage>2180</lpage>.<pub-id pub-id-type="pmid">36996330</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0005"><mixed-citation publication-type="journal" id="pro70024-cit-0005">
<string-name>
<surname>Baldy</surname>
<given-names>P</given-names>
</string-name>. <article-title>Metabolisme du &#x003b3;&#x02010;aminobutyrate chez Agaricus bisporus III. La succinate&#x02010;semialdehyde:NAD(P)+ oxydoreductase</article-title>. <source>Physiol Planctarum</source>. <year>1977</year>;<volume>40</volume>(<issue>2</issue>):<elocation-id>7</elocation-id>.</mixed-citation></ref><ref id="pro70024-bib-0006"><mixed-citation publication-type="journal" id="pro70024-cit-0006">
<string-name>
<surname>Black</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Vasiliou</surname>
<given-names>V</given-names>
</string-name>. <article-title>The aldehyde dehydrogenase gene superfamily resource center</article-title>. <source>Hum Genomics</source>. <year>2009</year>;<volume>4</volume>(<issue>2</issue>):<fpage>136</fpage>&#x02013;<lpage>142</lpage>.<pub-id pub-id-type="pmid">20038501</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0007"><mixed-citation publication-type="journal" id="pro70024-cit-0007">
<string-name>
<surname>Brennenstuhl</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Didiasova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Assmann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Molla</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Jung&#x02010;Klawitter</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Succinic semialdehyde dehydrogenase deficiency: in vitro and in silico characterization of a novel pathogenic missense variant and analysis of the mutational spectrum of ALDH5A1</article-title>. <source>Int J Mol Sci</source>. <year>2020</year>;<volume>21</volume>(<issue>22</issue>):<elocation-id>8578</elocation-id>.<pub-id pub-id-type="pmid">33203024</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0008"><mixed-citation publication-type="journal" id="pro70024-cit-0008">
<string-name>
<surname>Brocker</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lassen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Estey</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pappa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cantore</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Orlova</surname>
<given-names>VV</given-names>
</string-name>, et al. <article-title>Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress</article-title>. <source>J Biol Chem</source>. <year>2010</year>;<volume>285</volume>(<issue>24</issue>):<fpage>18452</fpage>&#x02013;<lpage>18463</lpage>.<pub-id pub-id-type="pmid">20207735</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0009"><mixed-citation publication-type="journal" id="pro70024-cit-0009">
<string-name>
<surname>Busch</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Fromm</surname>
<given-names>H</given-names>
</string-name>. <article-title>Plant succinic semialdehyde dehydrogenase. Cloning, purification, localization in mitochondria, and regulation by adenine nucleotides</article-title>. <source>Plant Physiol</source>. <year>1999</year>;<volume>121</volume>(<issue>2</issue>):<fpage>589</fpage>&#x02013;<lpage>597</lpage>.<pub-id pub-id-type="pmid">10517851</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0010"><mixed-citation publication-type="journal" id="pro70024-cit-0010">
<string-name>
<surname>Canto</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Menzies</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Auwerx</surname>
<given-names>J</given-names>
</string-name>. <article-title>Nad(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus</article-title>. <source>Cell Metab</source>. <year>2015</year>;<volume>22</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">26118927</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0011"><mixed-citation publication-type="journal" id="pro70024-cit-0011">
<string-name>
<surname>Cao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Locy</surname>
<given-names>RD</given-names>
</string-name>. <article-title>Characterization of the recombinant succinic semi&#x02010;aldehyde dehydrogenase from <italic toggle="yes">Saccharomyces cerevisiae</italic>
</article-title>. <source>Yeast</source>. <year>2014</year>;<volume>31</volume>(<issue>10</issue>):<fpage>411</fpage>&#x02013;<lpage>420</lpage>.<pub-id pub-id-type="pmid">25092794</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0012"><mixed-citation publication-type="journal" id="pro70024-cit-0012">
<string-name>
<surname>Chambliss</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Caudle</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Hinson</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Moomaw</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Slaughter</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Jakobs</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Molecular cloning of the mature NAD(+)&#x02010;dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression</article-title>. <source>J Biol Chem</source>. <year>1995</year>;<volume>270</volume>(<issue>1</issue>):<fpage>461</fpage>&#x02013;<lpage>467</lpage>.<pub-id pub-id-type="pmid">7814412</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0013"><mixed-citation publication-type="journal" id="pro70024-cit-0013">
<string-name>
<surname>Chambliss</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</string-name>. <article-title>Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum</article-title>. <source>Int J Biochem</source>. <year>1992</year>;<volume>24</volume>(<issue>9</issue>):<fpage>1493</fpage>&#x02013;<lpage>1499</lpage>.<pub-id pub-id-type="pmid">1426531</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0014"><mixed-citation publication-type="journal" id="pro70024-cit-0014">
<string-name>
<surname>Cozzani</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Fazio</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Felici</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Barletta</surname>
<given-names>G</given-names>
</string-name>. <article-title>Separation and characterization of NAD&#x02010; and NADP&#x02010;specific succinate&#x02010;semialdehyde dehydrogenase from <italic toggle="yes">Escherichia coli</italic> K&#x02010;12 3300</article-title>. <source>Biochim Biophys Acta</source>. <year>1980</year>;<volume>613</volume>(<issue>2</issue>):<fpage>309</fpage>&#x02013;<lpage>317</lpage>.<pub-id pub-id-type="pmid">7004491</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0015"><mixed-citation publication-type="journal" id="pro70024-cit-0015">
<string-name>
<surname>de Carvalho</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Warren</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Rhee</surname>
<given-names>KY</given-names>
</string-name>. <article-title>On the chemical mechanism of succinic semialdehyde dehydrogenase (GabD1) from <italic toggle="yes">Mycobacterium tuberculosis</italic>
</article-title>. <source>Arch Biochem Biophys</source>. <year>2011</year>;<volume>509</volume>(<issue>1</issue>):<fpage>90</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">21303655</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0016"><mixed-citation publication-type="journal" id="pro70024-cit-0016">
<string-name>
<surname>DiBacco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Pop</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Salomons</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Hanson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Roullet</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</string-name>, et al. <article-title>Novel ALDH5A1 variants and genotype. Phenotype correlation is SSADH deficiency</article-title>. <source>Neurology</source>. <year>2020</year>;<volume>95</volume>(<issue>19</issue>):<fpage>e2675</fpage>&#x02013;<lpage>e2682</lpage>.<pub-id pub-id-type="pmid">32887777</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0017"><mixed-citation publication-type="journal" id="pro70024-cit-0017">
<string-name>
<surname>Didi&#x000e1;&#x00161;ov&#x000e1;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Banning</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brennenstuhl</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jung&#x02010;Klawitter</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cinquemani</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Opladen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Succinic semialdehyde dehydrogenase deficiency: an update</article-title>. <source>Cells</source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<elocation-id>477</elocation-id>.<pub-id pub-id-type="pmid">32093054</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0018"><mixed-citation publication-type="journal" id="pro70024-cit-0018">
<string-name>
<surname>Didiasova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cesaro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Feldhoff</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bettin</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tiegel</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fussgen</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Functional characterization of a spectrum of genetic variants in a family with succinic semialdehyde dehydrogenase deficiency</article-title>. <source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>(<issue>10</issue>):<elocation-id>5237</elocation-id>.<pub-id pub-id-type="pmid">38791277</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0019"><mixed-citation publication-type="journal" id="pro70024-cit-0019">
<string-name>
<surname>Dong</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>. <article-title>mTM&#x02010;align: an algorithm for fast and accurate multiple protein structure alignment</article-title>. <source>Bioinformatics</source>. <year>2018</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1719</fpage>&#x02013;<lpage>1725</lpage>.<pub-id pub-id-type="pmid">29281009</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0020"><mixed-citation publication-type="journal" id="pro70024-cit-0020">
<string-name>
<surname>Donnelly</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Succinic semialdehyde dehydrogenases of <italic toggle="yes">Escherichia coli</italic>: their role in the degradation of p&#x02010;hydroxyphenylacetate and gamma&#x02010;aminobutyrate</article-title>. <source>Eur J Biochem</source>. <year>1981</year>;<volume>113</volume>(<issue>3</issue>):<fpage>555</fpage>&#x02013;<lpage>561</lpage>.<pub-id pub-id-type="pmid">7011797</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0021"><mixed-citation publication-type="journal" id="pro70024-cit-0021">
<string-name>
<surname>Embree</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Albers</surname>
<given-names>RW</given-names>
</string-name>. <article-title>Succinic semialdehyde dehydrogenase from human brain</article-title>. <source>Biochem Pharmacol</source>. <year>1964</year>;<volume>13</volume>:<fpage>1209</fpage>&#x02013;<lpage>1217</lpage>.<pub-id pub-id-type="pmid">14222518</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0022"><mixed-citation publication-type="journal" id="pro70024-cit-0022">
<string-name>
<surname>Federhen</surname>
<given-names>S</given-names>
</string-name>. <article-title>The NCBI taxonomy database</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>:<fpage>D136</fpage>&#x02013;<lpage>D143</lpage>.<pub-id pub-id-type="pmid">22139910</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0023"><mixed-citation publication-type="journal" id="pro70024-cit-0023">
<string-name>
<surname>Feehily</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>O'Byrne</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Karatzas</surname>
<given-names>KA</given-names>
</string-name>. <article-title>Functional gamma&#x02010;aminobutyrate shunt in <italic toggle="yes">Listeria monocytogenes</italic>: role in acid tolerance and succinate biosynthesis</article-title>. <source>Appl Environ Microbiol</source>. <year>2013</year>;<volume>79</volume>(<issue>1</issue>):<fpage>74</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">23064337</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0024"><mixed-citation publication-type="journal" id="pro70024-cit-0024">
<string-name>
<surname>Fu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>. <article-title>CD&#x02010;HIT: accelerated for clustering the next&#x02010;generation sequencing data</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>(<issue>23</issue>):<fpage>3150</fpage>&#x02013;<lpage>3152</lpage>.<pub-id pub-id-type="pmid">23060610</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0025"><mixed-citation publication-type="journal" id="pro70024-cit-0025">
<string-name>
<surname>Fuhrer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sauer</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Vitkup</surname>
<given-names>D</given-names>
</string-name>. <article-title>Computational prediction and experimental verification of the gene encoding the NAD<sup>+</sup>/NADP<sup>+</sup>&#x02010;dependent succinate semialdehyde dehydrogenase in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>J Bacteriol</source>. <year>2007</year>;<volume>189</volume>(<issue>22</issue>):<fpage>8073</fpage>&#x02013;<lpage>8078</lpage>.<pub-id pub-id-type="pmid">17873044</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0026"><mixed-citation publication-type="journal" id="pro70024-cit-0026">
<string-name>
<surname>Guindon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dufayard</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Lefort</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Anisimova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hordijk</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gascuel</surname>
<given-names>O</given-names>
</string-name>. <article-title>New algorithms and methods to estimate maximum&#x02010;likelihood phylogenies: assessing the performance of phyml 3.0</article-title>. <source>Syst Biol</source>. <year>2010</year>;<volume>59</volume>(<issue>3</issue>):<fpage>307</fpage>&#x02013;<lpage>321</lpage>.<pub-id pub-id-type="pmid">20525638</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0027"><mixed-citation publication-type="journal" id="pro70024-cit-0027">
<string-name>
<surname>Hagberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Swart</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chult</surname>
<given-names>D</given-names>
</string-name>. <part-title>Exploring network structure, dynamics, and function using networkx</part-title>. <source>Proceedings of the 7th Python in Science Conferences (SciPy 2008)</source>. Volume <volume>6</volume>; <year>2008</year>.</mixed-citation></ref><ref id="pro70024-bib-0028"><mixed-citation publication-type="journal" id="pro70024-cit-0028">
<string-name>
<surname>Hockenberry</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Wilke</surname>
<given-names>CO</given-names>
</string-name>. <article-title>Evolutionary couplings detect side&#x02010;chain interactions</article-title>. <source>PeerJ</source>. <year>2019</year>;<volume>7</volume>:<elocation-id>e7280</elocation-id>.<pub-id pub-id-type="pmid">31328041</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0029"><mixed-citation publication-type="journal" id="pro70024-cit-0029">
<string-name>
<surname>Hsu</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Foos</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Role of synaptic vesicle proton gradient and protein phosphorylation on ATP&#x02010;mediated activation of membrane&#x02010;associated brain glutamate decarboxylase</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>(<issue>34</issue>):<fpage>24366</fpage>&#x02013;<lpage>24371</lpage>.<pub-id pub-id-type="pmid">10446215</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0030"><mixed-citation publication-type="journal" id="pro70024-cit-0030">
<string-name>
<surname>Hsu</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Shibuya</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>A</given-names>
</string-name>. <article-title>Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary structure, and expression in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>J Biol Chem</source>. <year>1992</year>;<volume>267</volume>(<issue>5</issue>):<fpage>3030</fpage>&#x02013;<lpage>3037</lpage>.<pub-id pub-id-type="pmid">1737758</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0031"><mixed-citation publication-type="journal" id="pro70024-cit-0031">
<string-name>
<surname>Hu</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Obie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Valle</surname>
<given-names>D</given-names>
</string-name>. <article-title>Molecular enzymology of mammalian delta1&#x02010;pyrroline&#x02010;5&#x02010;carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>(<issue>10</issue>):<fpage>6754</fpage>&#x02013;<lpage>6762</lpage>.<pub-id pub-id-type="pmid">10037775</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0032"><mixed-citation publication-type="journal" id="pro70024-cit-0032">
<string-name>
<surname>Hurley</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Perez&#x02010;Miller</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Breen</surname>
<given-names>H</given-names>
</string-name>. <article-title>Order and disorder in mitochondrial aldehyde dehydrogenase</article-title>. <source>Chem Biol Interact</source>. <year>2001</year>;<volume>130&#x02010;132</volume>(<issue>1&#x02013;3</issue>):<fpage>3</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0033"><mixed-citation publication-type="journal" id="pro70024-cit-0033">
<string-name>
<surname>Ito</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Osanai</surname>
<given-names>T</given-names>
</string-name>. <article-title>Unconventional biochemical regulation of the oxidative pentose phosphate pathway in the model cyanobacterium Synechocystis sp. Pcc 6803</article-title>. <source>Biochem J</source>. <year>2020</year>;<volume>477</volume>(<issue>7</issue>):<fpage>1309</fpage>&#x02013;<lpage>1321</lpage>.<pub-id pub-id-type="pmid">32227111</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0034"><mixed-citation publication-type="journal" id="pro70024-cit-0034">
<string-name>
<surname>Jackson</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Brocker</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Black</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Vasiliou</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nebert</surname>
<given-names>DW</given-names>
</string-name>, et al. <article-title>Update on the aldehyde dehydrogenase gene (ALDH) superfamily</article-title>. <source>Hum Genomics</source>. <year>2011</year>;<volume>5</volume>(<issue>4</issue>):<fpage>283</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">21712190</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0035"><mixed-citation publication-type="journal" id="pro70024-cit-0035">
<string-name>
<surname>Jang</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Chi</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>KS</given-names>
</string-name>. <article-title>Kinetic and structural characterization for cofactor preference of succinic semialdehyde dehydrogenase from <italic toggle="yes">Streptococcus pyogenes</italic>
</article-title>. <source>Mol Cells</source>. <year>2014</year>;<volume>37</volume>(<issue>10</issue>):<fpage>719</fpage>&#x02013;<lpage>726</lpage>.<pub-id pub-id-type="pmid">25256219</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0036"><mixed-citation publication-type="journal" id="pro70024-cit-0036">
<string-name>
<surname>Jorgensen</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Chandrasekhar</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Madura</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Impey</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source>J Chem Phys</source>. <year>1983</year>;<volume>79</volume>:<fpage>926</fpage>&#x02013;<lpage>935</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0037"><mixed-citation publication-type="journal" id="pro70024-cit-0037">
<string-name>
<surname>Kang</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>YB</given-names>
</string-name>, <string-name>
<surname>Huh</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>OS</given-names>
</string-name>. <article-title>High&#x02010;level expression and characterization of the recombinant enzyme, and tissue distribution of human succinic semialdehyde dehydrogenase</article-title>. <source>Protein Expr Purif</source>. <year>2005</year>;<volume>44</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">16199352</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0038"><mixed-citation publication-type="journal" id="pro70024-cit-0038">
<string-name>
<surname>Kelson</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Secor McVoy</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Rizzo</surname>
<given-names>WB</given-names>
</string-name>. <article-title>Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization</article-title>. <source>Biochim Biophys Acta</source>. <year>1997</year>;<volume>1335</volume>(<issue>1&#x02013;2</issue>):<fpage>99</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">9133646</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0039"><mixed-citation publication-type="journal" id="pro70024-cit-0039">
<string-name>
<surname>Kikonyogo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pietruszko</surname>
<given-names>R</given-names>
</string-name>. <article-title>Aldehyde dehydrogenase from adult human brain that dehydrogenates gamma&#x02010;aminobutyraldehyde: purification, characterization, cloning and distribution</article-title>. <source>Biochem J</source>. <year>1996</year>;<volume>316</volume>(<issue>Pt 1</issue>):<fpage>317</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">8645224</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0040"><mixed-citation publication-type="journal" id="pro70024-cit-0040">
<string-name>
<surname>Kim</surname>
<given-names>YG</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>OS</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>BJ</given-names>
</string-name>, et al. <article-title>Redox&#x02010;switch modulation of human SSADH by dynamic catalytic loop</article-title>. <source>EMBO J</source>. <year>2009</year>;<volume>28</volume>(<issue>7</issue>):<fpage>959</fpage>&#x02013;<lpage>968</lpage>.<pub-id pub-id-type="pmid">19300440</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0041"><mixed-citation publication-type="journal" id="pro70024-cit-0041">
<string-name>
<surname>Kitamura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Naganuma</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nakahara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kihara</surname>
<given-names>A</given-names>
</string-name>. <article-title>Substrate specificity, plasma membrane localization, and lipid modification of the aldehyde dehydrogenase ALDH3B1</article-title>. <source>Biochim Biophys Acta</source>. <year>2013</year>;<volume>1831</volume>(<issue>8</issue>):<fpage>1395</fpage>&#x02013;<lpage>1401</lpage>.<pub-id pub-id-type="pmid">23721920</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0042"><mixed-citation publication-type="journal" id="pro70024-cit-0042">
<string-name>
<surname>Koch</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Harteis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blank</surname>
<given-names>ID</given-names>
</string-name>, <string-name>
<surname>Pestel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tietze</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Ochsenfeld</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Structural, biochemical, and computational studies reveal the mechanism of selective aldehyde dehydrogenase 1a1 inhibition by cytotoxic duocarmycin analogues</article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2015</year>;<volume>54</volume>(<issue>46</issue>):<fpage>13550</fpage>&#x02013;<lpage>13554</lpage>.<pub-id pub-id-type="pmid">26373694</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0043"><mixed-citation publication-type="journal" id="pro70024-cit-0043">
<string-name>
<surname>Koncitikova</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vigouroux</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kopecna</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sebela</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Morera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kopecny</surname>
<given-names>D</given-names>
</string-name>. <article-title>Kinetic and structural analysis of human ALDH9A1</article-title>. <source>Biosci Rep</source>. <year>2019</year>;<volume>39</volume>(<issue>4</issue>):<elocation-id>BSR20190558</elocation-id>.<pub-id pub-id-type="pmid">30914451</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0044"><mixed-citation publication-type="journal" id="pro70024-cit-0044">
<string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Punekar</surname>
<given-names>NS</given-names>
</string-name>. <article-title>Characterization of succinic semialdehyde dehydrogenase from <italic toggle="yes">Aspergillus niger</italic>
</article-title>. <source>Indian J Exp Biol</source>. <year>2015</year>;<volume>53</volume>(<issue>2</issue>):<fpage>67</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">25757236</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0045"><mixed-citation publication-type="journal" id="pro70024-cit-0045">
<string-name>
<surname>Langendorf</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Key</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Fenalti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kan</surname>
<given-names>WT</given-names>
</string-name>, <string-name>
<surname>Buckle</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Caradoc&#x02010;Davies</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>The x&#x02010;ray crystal structure of <italic toggle="yes">Escherichia coli</italic> succinic semialdehyde dehydrogenase; structural insights into NADP<sup>+</sup>/enzyme interactions</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>2</issue>):<elocation-id>e9280</elocation-id>.<pub-id pub-id-type="pmid">20174634</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0046"><mixed-citation publication-type="journal" id="pro70024-cit-0046">
<string-name>
<surname>Lee</surname>
<given-names>HHC</given-names>
</string-name>, <string-name>
<surname>Latzer</surname>
<given-names>IT</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Sahin</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Gene replacement therapies for inherited disorders of neurotransmission: current progress in succinic semialdehyde dehydrogenase deficiency</article-title>. <source>J Inherit Metab Dis</source>. <year>2024</year>;<volume>47</volume>(<issue>3</issue>):<fpage>476</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="pmid">38581234</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0047"><mixed-citation publication-type="journal" id="pro70024-cit-0047">
<string-name>
<surname>Lee</surname>
<given-names>HHC</given-names>
</string-name>, <string-name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>
<given-names>A</given-names>
</string-name>. <article-title>Enzyme replacement therapy for succinic semialdehyde dehydrogenase deficiency: relevance in gamma&#x02010;aminobutyric acid plasticity</article-title>. <source>J Child Neurol</source>. <year>2021</year>;<volume>36</volume>(<issue>13&#x02013;14</issue>):<fpage>1200</fpage>&#x02013;<lpage>1209</lpage>.<pub-id pub-id-type="pmid">33624531</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0048"><mixed-citation publication-type="journal" id="pro70024-cit-0048">
<string-name>
<surname>Lemoine</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Domelevo Entfellner</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Wilkinson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Correia</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Davila Felipe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>De Oliveira</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Renewing Felsenstein's phylogenetic bootstrap in the era of big data</article-title>. <source>Nature</source>. <year>2018</year>;<volume>556</volume>(<issue>7702</issue>):<fpage>452</fpage>&#x02013;<lpage>456</lpage>.<pub-id pub-id-type="pmid">29670290</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0049"><mixed-citation publication-type="journal" id="pro70024-cit-0049">
<string-name>
<surname>Maier</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kasavajhala</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wickstrom</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hauser</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Simmerling</surname>
<given-names>C</given-names>
</string-name>. <article-title>Ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</article-title>. <source>J Chem Theory Comput</source>. <year>2015</year>;<volume>11</volume>(<issue>8</issue>):<fpage>3696</fpage>&#x02013;<lpage>3713</lpage>.<pub-id pub-id-type="pmid">26574453</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0050"><mixed-citation publication-type="journal" id="pro70024-cit-0050">
<string-name>
<surname>Malaspina</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Picklo</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Jakobs</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Snead</surname>
<given-names>OC</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</string-name>. <article-title>Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma&#x02010;hydroxybutyrate associated with its deficiency</article-title>. <source>Hum Genomics</source>. <year>2009</year>;<volume>3</volume>(<issue>2</issue>):<fpage>106</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">19164088</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0051"><mixed-citation publication-type="journal" id="pro70024-cit-0051">
<string-name>
<surname>Marchal</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Branlant</surname>
<given-names>G</given-names>
</string-name>. <article-title>Evidence for the chemical activation of essential cys&#x02010;302 upon cofactor binding to nonphosphorylating glyceraldehyde 3&#x02010;phosphate dehydrogenase from <italic toggle="yes">Streptococcus mutans</italic>
</article-title>. <source>Biochemistry</source>. <year>1999</year>;<volume>38</volume>(<issue>39</issue>):<fpage>12950</fpage>&#x02013;<lpage>12958</lpage>.<pub-id pub-id-type="pmid">10504267</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0052"><mixed-citation publication-type="journal" id="pro70024-cit-0052">
<string-name>
<surname>Marchitti</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Orlicky</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Vasiliou</surname>
<given-names>V</given-names>
</string-name>. <article-title>Expression and initial characterization of human ALDH3B1</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2007</year>;<volume>356</volume>(<issue>3</issue>):<fpage>792</fpage>&#x02013;<lpage>798</lpage>.<pub-id pub-id-type="pmid">17382292</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0053"><mixed-citation publication-type="journal" id="pro70024-cit-0053">
<string-name>
<surname>Menduti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Biamino</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vittorini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vesco</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Puccinelli</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Porta</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Succinic semialdehyde dehydrogenase deficiency: the combination of a novel ALDH5A1 gene mutation and a missense snp strongly affects ssadh enzyme activity and stability</article-title>. <source>Mol Genet Metab</source>. <year>2018</year>;<volume>124</volume>(<issue>3</issue>):<fpage>210</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">29895405</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0054"><mixed-citation publication-type="journal" id="pro70024-cit-0054">
<string-name>
<surname>Mirdita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schutze</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Moriwaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Heo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ovchinnikov</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Steinegger</surname>
<given-names>M</given-names>
</string-name>. <article-title>Colabfold: making protein folding accessible to all</article-title>. <source>Nat Methods</source>. <year>2022</year>;<volume>19</volume>(<issue>6</issue>):<fpage>679</fpage>&#x02013;<lpage>682</lpage>.<pub-id pub-id-type="pmid">35637307</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0055"><mixed-citation publication-type="journal" id="pro70024-cit-0055">
<string-name>
<surname>Mirdita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Steinegger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Soding</surname>
<given-names>J</given-names>
</string-name>. <article-title>MMseqs2 desktop and local web server app for fast, interactive sequence searches</article-title>. <source>Bioinformatics</source>. <year>2019</year>;<volume>35</volume>(<issue>16</issue>):<fpage>2856</fpage>&#x02013;<lpage>2858</lpage>.<pub-id pub-id-type="pmid">30615063</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0056"><mixed-citation publication-type="journal" id="pro70024-cit-0056">
<string-name>
<surname>Moretti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Donini</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sobol</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Rizzi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Garavaglia</surname>
<given-names>S</given-names>
</string-name>. <article-title>Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<elocation-id>35710</elocation-id>.<pub-id pub-id-type="pmid">27759097</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0057"><mixed-citation publication-type="journal" id="pro70024-cit-0057">
<string-name>
<surname>Munoz&#x02010;Clares</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Casanova&#x02010;Figueroa</surname>
<given-names>K</given-names>
</string-name>. <article-title>The importance of assessing aldehyde substrate inhibition for the correct determination of kinetic parameters and mechanisms: the case of the ALDH enzymes</article-title>. <source>Chem Biol Interact</source>. <year>2019</year>;<volume>305</volume>:<fpage>86</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">30928398</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0058"><mixed-citation publication-type="journal" id="pro70024-cit-0058">
<string-name>
<surname>Munoz&#x02010;Clares</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Gonzalez&#x02010;Segura</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Murillo&#x02010;Melo</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Riveros&#x02010;Rosas</surname>
<given-names>H</given-names>
</string-name>. <article-title>Mechanisms of protection against irreversible oxidation of the catalytic cysteine of ALDH enzymes: possible role of vicinal cysteines</article-title>. <source>Chem Biol Interact</source>. <year>2017</year>;<volume>276</volume>:<fpage>52</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">28216341</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0059"><mixed-citation publication-type="journal" id="pro70024-cit-0059">
<string-name>
<surname>Murphy</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Amarnath</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Picklo</surname>
<given-names>MJ</given-names>
<suffix>Sr</suffix>
</string-name>. <article-title>Oxidation of 4&#x02010;hydroxy&#x02010;2&#x02010;nonenal by succinic semialdehyde dehydrogenase (ALDH5A)</article-title>. <source>J Neurochem</source>. <year>2003</year>;<volume>86</volume>(<issue>2</issue>):<fpage>298</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">12871571</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0060"><mixed-citation publication-type="journal" id="pro70024-cit-0060">
<string-name>
<surname>Murtas</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marcone</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Peracchi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zangelmi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pollegioni</surname>
<given-names>L</given-names>
</string-name>. <article-title>Biochemical and biophysical characterization of recombinant human 3&#x02010;phosphoglycerate dehydrogenase</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>8</issue>):<elocation-id>4231</elocation-id>.<pub-id pub-id-type="pmid">33921788</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0061"><mixed-citation publication-type="journal" id="pro70024-cit-0061">
<string-name>
<surname>Orlando</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Buchholz</surname>
<given-names>PCF</given-names>
</string-name>, <string-name>
<surname>Lotti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pleiss</surname>
<given-names>J</given-names>
</string-name>. <article-title>The GH19 engineering database: sequence diversity, substrate scope, and evolution in glycoside hydrolase family 19</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>10</issue>):<elocation-id>e0256817</elocation-id>.<pub-id pub-id-type="pmid">34699529</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0062"><mixed-citation publication-type="journal" id="pro70024-cit-0062">
<string-name>
<surname>Paladkong</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pimviriyakul</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Phonbuppha</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Maenpuen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chaiyen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tinikul</surname>
<given-names>R</given-names>
</string-name>. <article-title>Mechanistic roles of the neighbouring cysteine in enhancing nucleophilicity of catalytic residue in a two&#x02010;cysteine succinic semialdehyde dehydrogenase</article-title>. <source>FEBS J</source>. <year>2022</year>;<volume>290</volume>:<fpage>2449</fpage>&#x02013;<lpage>2462</lpage>.<pub-id pub-id-type="pmid">36177488</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0063"><mixed-citation publication-type="journal" id="pro70024-cit-0063">
<string-name>
<surname>Park</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rhee</surname>
<given-names>S</given-names>
</string-name>. <article-title>Structural basis for a cofactor&#x02010;dependent oxidation protection and catalysis of cyanobacterial succinic semialdehyde dehydrogenase</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>22</issue>):<fpage>15760</fpage>&#x02013;<lpage>15770</lpage>.<pub-id pub-id-type="pmid">23589281</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0064"><mixed-citation publication-type="journal" id="pro70024-cit-0064">
<string-name>
<surname>Park</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>KS</given-names>
</string-name>. <article-title>Kinetic characterization and molecular modeling of NAD(P)(+)&#x02010;dependent succinic semialdehyde dehydrogenase from <italic toggle="yes">Bacillus subtilis</italic> as an <italic toggle="yes">Ortholog ynei</italic>
</article-title>. <source>J Microbiol Biotechnol</source>. <year>2014</year>;<volume>24</volume>(<issue>7</issue>):<fpage>954</fpage>&#x02013;<lpage>958</lpage>.<pub-id pub-id-type="pmid">24809290</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0065"><mixed-citation publication-type="journal" id="pro70024-cit-0065">
<string-name>
<surname>Phonbuppha</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Maenpuen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Munkajohnpong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chaiyen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tinikul</surname>
<given-names>R</given-names>
</string-name>. <article-title>Selective determination of the catalytic cysteine pK(a) of two&#x02010;cysteine succinic semialdehyde dehydrogenase from <italic toggle="yes">Acinetobacter baumannii</italic> using burst kinetics and enzyme adduct formation</article-title>. <source>FEBS J</source>. <year>2018</year>;<volume>285</volume>(<issue>13</issue>):<fpage>2504</fpage>&#x02013;<lpage>2519</lpage>.<pub-id pub-id-type="pmid">29734522</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0066"><mixed-citation publication-type="journal" id="pro70024-cit-0066">
<string-name>
<surname>Pop</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DEC</given-names>
</string-name>, <string-name>
<surname>Kirby</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Walters</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Mahmoudi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Functional analysis of thirty&#x02010;four suspected pathogenic missense variants in ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency</article-title>. <source>Mol Genet Metab</source>. <year>2020</year>;<volume>130</volume>(<issue>3</issue>):<fpage>172</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">32402538</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0067"><mixed-citation publication-type="journal" id="pro70024-cit-0067">
<string-name>
<surname>Rice</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Longden</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bleasby</surname>
<given-names>A</given-names>
</string-name>. <article-title>Emboss: the european molecular biology open software suite</article-title>. <source>Trends Genet</source>. <year>2000</year>;<volume>16</volume>(<issue>6</issue>):<fpage>276</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">10827456</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0068"><mixed-citation publication-type="journal" id="pro70024-cit-0068">
<string-name>
<surname>Rivett</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Tipton</surname>
<given-names>KF</given-names>
</string-name>. <article-title>Kinetic studies with rat&#x02010;brain succinic&#x02010;semialdehyde dehydrogenase</article-title>. <source>Eur J Biochem</source>. <year>1981</year>;<volume>117</volume>(<issue>1</issue>):<fpage>187</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">7262085</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0069"><mixed-citation publication-type="journal" id="pro70024-cit-0069">
<string-name>
<surname>Rothacker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ilg</surname>
<given-names>T</given-names>
</string-name>. <article-title>Functional characterization of a <italic toggle="yes">Drosophila melanogaster</italic> succinic semialdehyde dehydrogenase and a non&#x02010;specific aldehyde dehydrogenase</article-title>. <source>Insect Biochem Mol Biol</source>. <year>2008</year>;<volume>38</volume>(<issue>3</issue>):<fpage>354</fpage>&#x02013;<lpage>366</lpage>.<pub-id pub-id-type="pmid">18252249</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0070"><mixed-citation publication-type="journal" id="pro70024-cit-0070">
<string-name>
<surname>Rothacker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Werr</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ilg</surname>
<given-names>T</given-names>
</string-name>. <article-title>Molecular cloning, partial genomic structure and functional characterization of succinic semialdehyde dehydrogenase genes from the parasitic insects <italic toggle="yes">Lucilia cuprina</italic> and <italic toggle="yes">Ctenocephalides felis</italic>
</article-title>. <source>Insect Mol Biol</source>. <year>2008</year>;<volume>17</volume>(<issue>3</issue>):<fpage>279</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">18477242</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0071"><mixed-citation publication-type="journal" id="pro70024-cit-0071">
<string-name>
<surname>Ryzlak</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Pietruszko</surname>
<given-names>R</given-names>
</string-name>. <article-title>Human brain &#x0201c;high km&#x0201d; aldehyde dehydrogenase: purification, characterization, and identification as NAD<sup>+</sup>&#x02010;dependent succinic semialdehyde dehydrogenase</article-title>. <source>Arch Biochem Biophys</source>. <year>1988</year>;<volume>266</volume>(<issue>2</issue>):<fpage>386</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">3190233</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0072"><mixed-citation publication-type="book" id="pro70024-cit-0072">
<string-name>
<surname>Sayers</surname>
<given-names>E.</given-names>
</string-name>
<year>2022</year>. <source>A General Introduction to the E&#x02010;utilities</source>. <publisher-loc>Bethesda</publisher-loc>: <publisher-name>National Centre for Biotechnology Information</publisher-name>.</mixed-citation></ref><ref id="pro70024-bib-0073"><mixed-citation publication-type="journal" id="pro70024-cit-0073">
<string-name>
<surname>Scheurer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rodenkirch</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Siggel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bernardi</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Schulten</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tajkhorshid</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Pycontact: rapid, customizable, and visual analysis of non&#x02010;covalent interactions in MD simulations</article-title>. <source>Biophys J</source>. <year>2018</year>;<volume>114</volume>(<issue>3</issue>):<fpage>577</fpage>&#x02013;<lpage>583</lpage>.<pub-id pub-id-type="pmid">29414703</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0074"><mixed-citation publication-type="journal" id="pro70024-cit-0074">
<string-name>
<surname>Srivastava</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Moxley</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Henzl</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Becker</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Tanner</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>The three&#x02010;dimensional structural basis of type II hyperprolinemia</article-title>. <source>J Mol Biol</source>. <year>2012</year>;<volume>420</volume>(<issue>3</issue>):<fpage>176</fpage>&#x02013;<lpage>189</lpage>.<pub-id pub-id-type="pmid">22516612</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0075"><mixed-citation publication-type="journal" id="pro70024-cit-0075">
<string-name>
<surname>Stagos</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Brocker</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Donald</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Orlicky</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde&#x02010;metabolizing enzyme</article-title>. <source>Drug Metab Dispos</source>. <year>2010</year>;<volume>38</volume>(<issue>10</issue>):<fpage>1679</fpage>&#x02013;<lpage>1687</lpage>.<pub-id pub-id-type="pmid">20616185</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0076"><mixed-citation publication-type="journal" id="pro70024-cit-0076">
<string-name>
<surname>Stein</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Imai</surname>
<given-names>S</given-names>
</string-name>. <article-title>The dynamic regulation of NAD metabolism in mitochondria</article-title>. <source>Trends Endocrinol Metab</source>. <year>2012</year>;<volume>23</volume>(<issue>9</issue>):<fpage>420</fpage>&#x02013;<lpage>428</lpage>.<pub-id pub-id-type="pmid">22819213</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0077"><mixed-citation publication-type="journal" id="pro70024-cit-0077">
<string-name>
<surname>Steinegger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Meier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mirdita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vohringer</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Haunsberger</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Soding</surname>
<given-names>J</given-names>
</string-name>. <article-title>HH&#x02010;suite3 for fast remote homology detection and deep protein annotation</article-title>. <source>BMC Bioinformatics</source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<elocation-id>473</elocation-id>.<pub-id pub-id-type="pmid">31521110</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0078"><mixed-citation publication-type="journal" id="pro70024-cit-0078">
<string-name>
<surname>Steinegger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Soding</surname>
<given-names>J</given-names>
</string-name>. <article-title>MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets</article-title>. <source>Nat Biotechnol</source>. <year>2017</year>;<volume>35</volume>(<issue>11</issue>):<fpage>1026</fpage>&#x02013;<lpage>1028</lpage>.<pub-id pub-id-type="pmid">29035372</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0079"><mixed-citation publication-type="journal" id="pro70024-cit-0079">
<string-name>
<surname>Strickland</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Krupenko</surname>
<given-names>NI</given-names>
</string-name>, <string-name>
<surname>Dubard</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Tsybovsky</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Krupenko</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Enzymatic properties of ALDH1L2, a mitochondrial 10&#x02010;formyltetrahydrofolate dehydrogenase</article-title>. <source>Chem Biol Interact</source>. <year>2011</year>;<volume>191</volume>(<issue>1&#x02013;3</issue>):<fpage>129</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">21238436</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0080"><mixed-citation publication-type="journal" id="pro70024-cit-0080">
<string-name>
<surname>Su</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Demchak</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bader</surname>
<given-names>GD</given-names>
</string-name>. <article-title>Biological network exploration with cytoscape 3</article-title>. <source>Curr Protoc Bioinformatics</source>. <year>2014</year>;<volume>47</volume>:<fpage>8.13.1</fpage>&#x02013;<lpage>8.13.24</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0081"><mixed-citation publication-type="journal" id="pro70024-cit-0081">
<string-name>
<surname>Tokatly Latzer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Blau</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>DiBacco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Elsea</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Garcia&#x02010;Cazorla</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency</article-title>. <source>Mol Genet Metab</source>. <year>2024a</year>;<volume>142</volume>(<issue>1</issue>):<elocation-id>108363</elocation-id>.<pub-id pub-id-type="pmid">38452608</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0082"><mixed-citation publication-type="journal" id="pro70024-cit-0082">
<string-name>
<surname>Tokatly Latzer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>DiBacco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Arning</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tsuboyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>MacMullin</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>The presence and severity of epilepsy coincide with reduced gamma&#x02010;aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency</article-title>. <source>Epilepsia</source>. <year>2023a</year>;<volume>64</volume>(<issue>6</issue>):<fpage>1516</fpage>&#x02013;<lpage>1526</lpage>.<pub-id pub-id-type="pmid">36961285</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0083"><mixed-citation publication-type="journal" id="pro70024-cit-0083">
<string-name>
<surname>Tokatly Latzer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hanson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Garcia&#x02010;Cazorla</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tsuboyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>MacMullin</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency</article-title>. <source>Dev Med Child Neurol</source>. <year>2023b</year>;<volume>65</volume>:<fpage>1596</fpage>&#x02013;<lpage>1606</lpage>.<pub-id pub-id-type="pmid">37246331</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0084"><mixed-citation publication-type="journal" id="pro70024-cit-0084">
<string-name>
<surname>Tokatly Latzer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Roullet</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Afshar&#x02010;Saber</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HHC</given-names>
</string-name>, <string-name>
<surname>Bertoldi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McGinty</surname>
<given-names>GE</given-names>
</string-name>, et al. <article-title>Clinical and molecular outcomes from the 5&#x02010;year natural history study of ssadh deficiency, a model metabolic neurodevelopmental disorder</article-title>. <source>J Neurodev Disord</source>. <year>2024b</year>;<volume>16</volume>(<issue>1</issue>):<elocation-id>21</elocation-id>.<pub-id pub-id-type="pmid">38658850</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0085"><mixed-citation publication-type="journal" id="pro70024-cit-0085">
<string-name>
<surname>Tokatly Latzer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Roullet</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Cesaro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>DiBacco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Arning</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants</article-title>. <source>Hum Genet</source>. <year>2023c</year>;<volume>142</volume>(<issue>12</issue>):<fpage>1755</fpage>&#x02013;<lpage>1776</lpage>.<pub-id pub-id-type="pmid">37962671</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0086"><mixed-citation publication-type="journal" id="pro70024-cit-0086">
<string-name>
<surname>Toyokura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Oiwada</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kusano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tameshige</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tatematsu</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Succinic semialdehyde dehydrogenase is involved in the robust patterning of arabidopsis leaves along the adaxial&#x02013;abaxial axi</article-title>. <source>Plan Cell Physiol</source>. <year>2011</year>;<volume>52</volume>(<issue>8</issue>):<fpage>1340</fpage>&#x02013;<lpage>1353</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0087"><mixed-citation publication-type="journal" id="pro70024-cit-0087">
<string-name>
<surname>Varadi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bertoni</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Magana</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Paramval</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Pidruchna</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Radhakrishnan</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Alphafold protein structure database in 2024: providing structure coverage for over 214 million protein sequences</article-title>. <source>Nucleic Acids Res</source>. <year>2024</year>;<volume>52</volume>(<issue>D1</issue>):<fpage>D368</fpage>&#x02013;<lpage>D375</lpage>.<pub-id pub-id-type="pmid">37933859</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0088"><mixed-citation publication-type="journal" id="pro70024-cit-0088">
<string-name>
<surname>Vasiliou</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Nebert</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family</article-title>. <source>Hum Genomics</source>. <year>2005</year>;<volume>2</volume>(<issue>2</issue>):<fpage>138</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">16004729</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0089"><mixed-citation publication-type="journal" id="pro70024-cit-0089">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Kinetic characterization and structural modeling of an NADP(+)&#x02010;dependent succinic semialdehyde dehydrogenase from Anabaena sp. Pcc7120</article-title>. <source>Int J Biol Macromol</source>. <year>2018</year>;<volume>108</volume>:<fpage>615</fpage>&#x02013;<lpage>624</lpage>.<pub-id pub-id-type="pmid">29242124</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0090"><mixed-citation publication-type="journal" id="pro70024-cit-0090">
<string-name>
<surname>Xie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Kinetic and structural insights into enzymatic mechanism of succinic semialdehyde dehydrogenase from Cyanothece sp. Atcc51142</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>9</issue>):<elocation-id>e0239372</elocation-id>.<pub-id pub-id-type="pmid">32966327</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0091"><mixed-citation publication-type="journal" id="pro70024-cit-0091">
<string-name>
<surname>Yuan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>YR</given-names>
</string-name>. <article-title>Structural basis for cofactor and substrate selection by cyanobacterium succinic semialdehyde dehydrogenase</article-title>. <source>J Struct Biol</source>. <year>2013</year>;<volume>182</volume>(<issue>2</issue>):<fpage>125</fpage>&#x02013;<lpage>135</lpage>.<pub-id pub-id-type="pmid">23500184</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0092"><mixed-citation publication-type="journal" id="pro70024-cit-0092">
<string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>A</given-names>
</string-name>. <article-title>A QM/MM study of the catalytic mechanism of succinic semialdehyde dehydrogenase from Synechococcus sp. PCC 7002 and <italic toggle="yes">Salmonella typhimurium</italic>
</article-title>. <source>RSC Adv</source>. <year>2015</year>;<volume>5</volume>:<fpage>101672</fpage>&#x02013;<lpage>101682</lpage>.</mixed-citation></ref><ref id="pro70024-bib-0093"><mixed-citation publication-type="journal" id="pro70024-cit-0093">
<string-name>
<surname>Zhao</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>McCaffery</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ivins</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Neve</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Hogan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>WW</given-names>
</string-name>, et al. <article-title>Molecular identification of a major retinoic&#x02010;acid&#x02010;synthesizing enzyme, a retinaldehyde&#x02010;specific dehydrogenase</article-title>. <source>Eur J Biochem</source>. <year>1996</year>;<volume>240</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">8797830</pub-id>
</mixed-citation></ref><ref id="pro70024-bib-0094"><mixed-citation publication-type="journal" id="pro70024-cit-0094">
<string-name>
<surname>Zheng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Beliavsky</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tchigvintsev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brunzelle</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Flick</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Structure and activity of the NAD(P)+&#x02010;dependent succinate semialdehyde dehydrogenase ynei from <italic toggle="yes">Salmonella typhimurium</italic>
</article-title>. <source>Proteins</source>. <year>2013</year>;<volume>81</volume>(<issue>6</issue>):<fpage>1031</fpage>&#x02013;<lpage>1041</lpage>.<pub-id pub-id-type="pmid">23229889</pub-id>
</mixed-citation></ref></ref-list></back></article>